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Abbreviations 
ADH Alcohol dehydrogenase 
BMIMBF4 1-Butyl-3-methylimidazolium tetrafluoroborate                  
BSA Bovine serum albumin 
BsADH ADH from Bacillus stereothermophilus 
ClMBF Methyl o-chlorobenzoylformate 
ClMM Methyl (R)-o-chloromandelate 
CMA   trans-Cinnamaldehyde 
CMO Cinnamyl Alcohol 
DNA Deoxyribonucleic acid 
EDTA Ethylenediaminetetraacetic acid 
ee Enantiomeric excess 
EMO Ethyl 3-methyl-2-oxobutyrate 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
LB Luria Bertani medium 
MBF Methyl benzoylformate 
MES 2-(N-morpholino) ethanesulfonic acid 
MM Methyl (R)-mandelate 
NAD(P)+ Nicotinammide adenine dinucleotide (phosphate),oxidized form 
NAD(P)H Nicotinammide adenine dinucleotide (phosphate), reduced form 
NEB New England Biolabs 
PCR Polymerase chain reaction 
PMSF Phenylmethylsulfonyl fluoride 
SaADH ADH from Sulfolobus acidocaldarius 
SDR Short-chain dehydrogenase 
TaGDH Glucose dehydrogenase from Thermoplasma acidophilum 
TtADH ADH from Thermus thermophilus 
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Abstract 
Biocatalysis is well-matched to chemical synthesis in the pharmaceutical as 
well as the agrochemical and flavours industry. A significant number of 
products are chiral in at least one center, and many of them have multiple 
chiral centers. These compounds are usually manufactured in single isomer 
form since the current Food and Drug Administration regulations demand 
proof that the non-therapeutic isomer is non-toxic. The synthesis of a chiral 
center requires enantio and regioselective catalysts, and enzymes are 
consistently the most selective catalysts available being able to perform 
reactions under mild conditions of pH value, temperature, and pressure in 
aqueous solutions, a greener approach to chemistry, with remarkable 
chemo-, regio-, and stereoselectivity. Chiral alcohols are very important 
precursors for a large number of drugs, agrochemical and flavours. Their 
production by asymmetric bioreduction of a prochiral carbonyl precursor is 
becoming well-established in the field of biocatalysis. Enzymes that 
catalyze ketone reductions (known as ketoreductases) are a reliable source 
of high enantiomeric excess chiral alcohols.  
The aim of the present PhD research is to characterize new alcohol 
dehydrogenases (ADHs) for the synthesis of chiral secondary alcohols and 
the structural study of the isolated enzymes for the understanding of the 
structure-function relationships. 
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The basic approach was to identify oxidoreductases with these distinctive 
features, operational stability and NAD dependency, by looking for in the 
genome of thermophilic microorganisms for genes coding putative short-
chain dehydrogenases/reductases (SDR) with an acidic residue which 
determines NADH specificity in a particular position of the sequence. 
In the present work an applicative development of Thermus termophilus 
ADH in the asymmetric synthesis of two valuable chiral building blocks 
methyl (R)-mandelato and methyl (R)-o-chloromandelate at lab scale was 
carried out, and adaption of two different enzyme-coupled systems for the 
cofactor regeneration system was studied.  
Two novel NADH dependent-ADHs identified in the crenarchaeon 
Sulfolobus acidocaldarius  SaADH and SaADH2 were biochemically 
characterized, a suitable cofactor regeneration system for the analytical 
study of the stereoselectivity both enzymes was utilized, moreover, the 
solved SaADH2 3D structure was discussed.  
Finally, an applicative utilization of Bacillus stearothermophilus ADH both 
as an isolated enzyme, and in recombinant E. coli whole cells in the 
synthesis of cinnamyl alcohol, a versatile fine chemical, by chemoselective 
reduction of cinnamaldehyde at gram scale was described. 
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Sintesi 
La biocatalisi ha di recente assunto una crescente importanza nella sintesi 
chimica di prodotti nel settore agroalimentare, delle fragranze e soprattutto 
nel settore farmaceutico per la preparazione di composti 
enantiomericamente puri. Un numero significativo di farmaci sono chirali 
in almeno un centro e devono essere prodotti come singolo isomero, poiché 
la regolamentazione internazionale (Food and Drug Administration) 
richiede la certificazione che l’isomero non terapeutico sia non tossico. 
La sintesi di un centro chirale richiede catalizzatori enantio e regioselettivi, 
e gli enzimi sono i catalizzatori più selettivi disponibili per poter effettuare 
queste reazioni in condizioni blande di pH, temperatura e pressione in 
soluzione acquosa, un più verde approccio per la chimica, e con notevole 
chemo-, regio-e stereoselettività. Gli alcoli chirali sono precursori molto 
importanti per un gran numero di farmaci, agrochimici ed aromi.  
La produzione di alcoli chirali mediante riduzione asimmetrica di un 
precursore carbonilico prochirale è ben consolidata nel campo della 
biocatalisi. Gli enzimi che catalizzano la riduzione di chetoni, le 
ossidoriduttasi, sono in grado di fornire alcoli dall'elevatissima purezza 
ottica. Lo scopo del presente progetto di ricerca è la caratterizzazione di 
nuove alcol deidrogenasi (ADH) per la sintesi di alcoli secondari chirali e 
lo studio della relazione struttura-funzione degli enzimi isolati. L'approccio 
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di base è stato identificare ossidoriduttasi con due caratteristiche distintive, 
stabilità operativa e dipendenza dal NAD(H), cercando nel genoma di 
microrganismi termofili geni codificanti putative deidrogenasi/riduttasi a 
catena corta avente un residuo acidico in una particolare posizione della 
sequenza che determina la specificità per il NADH.  
Nel presente lavoro è stata realizzata la sintesi asimmetrica in scala di 
laboratorio di due precursori di notevole interesse applicativo, (R)-
mandelato di metile e (R)-o-cloro-mandelato di metile, mediante l'ADH di 
Thermus termophilus, e lo sviluppo di due diversi sistemi enzimatici per la 
rigenerazione del cofattore. 
Inoltre, due nuove ADH NADH-dipendenti individuate nel crenarchaeon 
Sulfolobus acidocaldarius, SaADH e SaADH2, sono state caratterizzate 
biochimicamente; per lo studio analitico della stereoselettività di entrambi 
gli enzimi è stato utilizzato un adeguato sistema di rigenerazione del 
cofattore. La struttura 3D di SaADH2 è stata risolta a 1.75 Å e discussa. 
Infine, un efficiente sistema di sintesi dell'alcol cinnamilico per riduzione 
chemoselettiva della cinnamaldeide è stato sviluppato, utilizzando l’alcol 
deidrogenasi di Bacillus stearothermophilus (BsADH), sia come enzima 
isolato sia in cellula intera.  
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Biocatalysis 
Biocatalysis is increasingly being used in synthetic routes to complex 
molecules of industrial interest. Biocatalysts not only commonly work 
under ambient conditions of temperature, pH value, and pressure in 
aqueous solutions, a greener approach to chemistry but, most importantly, 
are highly chemo-, regio-, and stereoselective and therefore of great interest 
in fine chemical synthesis. The main role for biocatalysis is in the 
agrochemical, flavours and pharmaceutical sector for the preparation of 
enantiomerically pure compounds. Compounds with a chiral centre are 
usually manufactured in single isomer form since the current Food and 
Drug Administration regulations demand proof that the non-therapeutic 
isomer is non-toxic. Many of these molecules are also structurally complex 
and contain multiple chiral centres.  
 
Chirality and drugs 
Chirality is a key factor in the efficacy of many drugs. The classic case of 
failure to take account of chirality concerned the drug thalidomide, a mild 
analgesic prescribed for pregnant women in the 1960s (Fig. 1). This 
relatively simple compound contains only one chiral centre yet the chirality 
proved crucial to the biological effects of the drug. Since the working 
environment of drugs in nature is chiral, enantiomers are not identical 
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chemical entities. With respect to their receptor complexes they have a 
diastereoisomeric relationship. In the case of thalidomide, no heed was 
taken of the potential consequences of this relationship and the drug was 
manufactured and sold as a racemic mixture. Tragically, women who had 
taken the drug gave birth to deformed offspring. Further research showed 
that only the S isomer was teratogenic and the R isomer was safe.  
 
(S)-(-)-N-(2,6-dioxo-3-piperidyl)phthalimide (R)-(+)-N-(2,6-dioxo-3-piperidyl)phthalimide 
or or 
(S)-thalidomide (R)-thalidomide 
Teratogenic Safe Analgesic 
 
Figure 1. Representation of the enantiomers of thalidomide. 
 
Drugs are compounds that in small amounts trigger a response in living 
organisms. Many processes within an organism sensitive to the action of a 
drug, such as the inhibition of an enzyme, the process of transport across 
the membrane, the binding of receptors, depend on the stereochemistry of 
the molecule-drug (Jamali et al. 1989; Sundby 2003 ). Biological activity, 
toxicity, or the metabolism of the drug can be very different for the 
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enantiomers of a chiral drug. In fact, there are many examples in which one 
enantiomer of a chiral drug has a therapeutically useful action and the other 
enantiomer but no, one enantiomer is toxic and the other is safe (see the 
case of thalidomide), one is agonist and the other is antagonistic (Table 1).  
 
Table 1. Enantiomers may confer benefits over racemates for therapeutic uses 
Properties of racemate Potential benefits of enantiomer 
 
One enantiomer is exclusively active 
 
Reduced dose and load on metabolism 
The other enantiomer is toxic Increased latitude in dose and broader 
use of the drug  
Enantiomers have different pharmaco- 
kinetics 
Better control of kinetics and dose 
Enantiomers metabolized at different  
rates in the same person 
Wider latitude in setting the dose; 
reduction in variability of patients’ 
responses 
Enantiomers metabolized at different 
 rates in the population 
Reduction in variability of patients’ 
responses; greater confidence in  
setting a single dose 
One enantiomer prone to interaction  
with key detoxification pathways 
Reduced interactions with other  
common drugs 
One enantiomer is agonist, the other 
antagonist 
Enhanced activity and reduction of  
dose 
Enantiomers vary in spectra of 
Pharmacological action and tissue  
specificity 
Increased specificity and reduced side 
effects for one enantiomer; use of other 
enantiomer for different indication 
 
It is now established that the enantiomers of racemates longer confer 
benefits in therapeutic use and, consequently, the production of single 
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enantiomer has become increasingly important and is currently performed 
by chemical synthesis or enzymatic. Enantiomers of chiral drugs may differ 
both quantitatively and qualitatively in their biological response. At one 
extreme, one enantiomer might have no effect. At the other extreme, both 
enantiomers have potent, but distinct, biological activity. 
 
Ways of producing enantiomers 
There are several ways to produce enantiomerically pure products, but still 
the most used techniques in industry are based on chirality of natural 
origin, the so-called chirality pool (Sundby 2003). In order to produce 
“new” chirality, it is common to distinguish between methods that are 
based on resolution of building blocks with a racemic origin and 
asymmetric synthesis. In the latter case, a prochiral starting material is 
converted to an optically active product using a chiral additive via an 
asymmetric reaction step. The different routes to enantiomerically pure 
building blocks are outlined in Scheme 1. It is important to emphasize the 
difference between asymmetric synthesis and kinetic resolution. The latter 
case involves a racemic chiral compound with a chiral reagent or an achiral 
reagent/chiral catalyst system. In either case, the two different enantiomers 
undergo reaction with different rates, thereby leading to a chiral enrichment  
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Scheme 1. Different routes to enantiomerically pure building blocks. 
 
in the product. In an ideal case, one enantiomer is converted to the product 
while the other stays intact. 
 This means that the enantiomeric excess of both product and substrate 
changes as the reaction progresses. Moreover, maximum yield in this 
reaction is 50%. On the other hand, asymmetric synthesis has a prochiral 
starting point, which ensures a theoretical yield of 100%. A chiral reagent 
or an achiral reagent/chiral catalyst system introduces chirality to the 
prochiral center, and the enantiomeric excess is constant during the 
reaction.  
The more classes of enzymes used in the enantioselective synthesis are the 
following: lipase, esterase, alcohol oxidase, nitrilase, transaminases, amino 
acid oxidase, and dehydrogenase/reductase (ADH).  
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Dehydrogenases/Reductases (ADHs) 
Dehydrogenases/Reductases, classified under E.C.1.1.1., are a group of 
dehydrogenase enzymes that occur in many organisms and facilitate the 
interconversion between alcohols and aldehydes or ketones with the 
reduction of nicotinamide adenine dinucleotide (NAD+ to NADH). These 
enzymes are ubiquitous in nature: Eucarya, Bacteria and Archaea, they 
play considerable process and production roles, for example in generation 
of potable alcohol, solvents and acetic acid. ADHs also support the growth 
of methylotrophs, oxidize alcohols and catalyse lignin degradation 
(Radianingtyas and Wright 2003). More recent studies have shown that 
mammalian ADH catalyzes retinol oxidation to provide retinal for retinoic 
acid synthesis, the active metabolite which controls a nuclear receptor 
signaling pathway (Duester 1996). Many studies have been addressed to 
characterize ADHs, mainly to understand their evolution and 
structure/function/stability relationship (Radianingtyas and Wright 2003) 
and develop their biotechnological potential mainly in the synthesis of the 
(S) or (R) enantiomers of alcohols from prochiral ketones (Hummel 1999). 
Fig. 2 shows an example of asymmetric bioreduction of an aromatic 
ketone.  
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Figure 2. Highly S-enantioselective ADH that produces 99% of (S) isomer and 1% of 
(R) will have an enantiomeric excess of 98%. The enantiomeric excess = ([S]-
[R]/[S]+[R]) × 100 
 
Recently, enzymatic processes using whole cell fermentation or isolated 
ADHs have attracted a growing interest for the commercial production of 
chiral alcohols (Breuer et al. 2004; Liese et al. 2000). 
 
Production of chiral alcohols with whole cells 
The biotechnological processes for the production of chiral alcohols by 
reducing prochiral ketones with whole cells are known since many decades. 
Enzymes utilized as whole cells are usually more stable due to the 
surrounding of their natural environment. Furthermore, the use of whole-
cell biocatalysts is sometimes desirable, as there is no need for downstream 
processing and purification of enzymes. Furthermore, especially in 
fermentative processes, the cells have internal cofactor regeneration, so that 
the addition of cheap co-substrate is sufficient to drive the reaction 
(Nakamura and Matsuda 2002; Faber 2004). On the other hand, when wild-
type microorganisms are used as biocatalysts, insufficient values for 
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selectivity and, in particular, enantioselectivity may occur due to the 
presence of multiple reductases in the cell that display different 
enantiopreferences or even modify the substrate in other undesired position 
(Faber 2000; Kaluzna et al. 2004; Johanson et al. 2005). Furthermore, the 
cellular content of the carbonyl reductase giving a desired enantiomer may 
be relatively low, because the enzyme gene might be weakly expressed. 
However, cloning and overexpression of the gene encoding the enzyme of 
interest are powerful tools in the solution of this problem.  
 
Production of chiral alcohols with isolated enzyme  
Since early application of ADHs in asymmetric synthesis using horse liver 
and yeast ADHs (Jones and Beck 1976) and Thermoanaerobacter brockii 
ADH (TbADH) (Keinan et al. 1986), screening efforts have been directed 
at various species of microorganisms, which has resulted in new ADHs that 
have distinctive substrate specificity, good efficiency, and high 
enantioselectivity.  
 
ADHs from thermophilic microorganisms 
Representative examples of ADHs from thermophilic microorganisms are 
medium-chain enzymes, including TbADH (Korkhin et al. 1998), the ADH 
from Bacillus stearothermophilus (BsADH) (Ceccarelli et al. 2004), and 
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two archaeal enzymes, the ADH from Aeropyrum pernix (Guy et al. 2003) 
and the well-known ADH from Sulfolobus solfataricus (SsADH) (Raia et 
al. 2001; Giordano et al. 2005; Friest et al. 2010). The latter is a tetrameric, 
S-specific, NAD-dependent zinc enzyme, which is more active on primary 
alcohols than on secondary alcohols and is poorly active on arylketones. By 
contrast, the thermophilic S-specific enzyme TbADH is NADP dependent 
and complements horse liver ADH by preferentially accepting acyclic 
ketones and secondary alcohols rapidly (Keinan et al 1986).  
 
ADHs from mesophilic microorganisms 
Representative examples of enzymes from mesophilic microorganisms are 
the NADP-dependent (R)-specific ADH from Lactobacillus brevis (LB-
RADH), which is active on aryl ketones and whose crystal structure has 
been solved (Schlieben et al. 2005), the NAD-dependent (S)-specific 1-
phenylethanol dehydrogenase from the denitrifying bacterium strain EbN1 
(PED), which was characterized and crystallized (Höffken et al. 2006), and 
the NAD-dependent ADH from Leifsonia sp. strain S749 (LsADH), which 
was found to be active on (R)-sec alcohols, aryl ketones, aldehydes, and 
keto esters and whose gene has recently been cloned for protein expression 
in Escherichia coli (Inoue et al. 2006). These enzymes are homotetrameric 
and belong to the short-chain NAD(P)(H)-dependent 
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dehydrogenase/reductase (SDR) superfamily (Kallberg et al. 2002). SDR 
enzymes have critical roles in lipid, amino acid, carbohydrate, cofactor, 
hormone and xenobiotic metabolism as well as to play a role as scaffolds 
for an NAD(P)(H) redox sensor system, of importance to control metabolic 
routes, transcription and signalling. SDRs are characterized by ~250 
residue subunits, a Gly motif in the coenzyme-binding regions, and a 
catalytic triad formed by the highly conserved residues Tyr, Lys, Ser, to 
which an Asn residue has been added according to the proposal of Filling et 
al. (2002) later supported by the LB-RADH structure (Schlieben et al. 
2005). Typically SDRs enzymes are non metal. However, LB-RADH 
contains Mg2+ having a structural role (Niefind et al. 2003). An important 
feature within the amino acid sequence will be discussed below. 
 
Research project aim 
The aim of my PhD research is to characterize new ADHs for the synthesis 
of chiral secondary alcohols as well as the structural study of the isolated 
enzymes for the understanding of the structure-function relationships. In 
particular, my attention was focused mainly on thermophilic ADHs 
belonging to the SDR superfamily.  
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Lines of activity 
The activity for my research project covers the following lines: 
- Identification of thermophilic ADHs belonging to the short-chain 
dehydrogenase/reductase (SDR) superfamily by genome sequence analysis. 
-  Cloning and expression in E. coli of the selected gene and purification of 
the protein. These issues can be achieved using the conventional techniques 
of molecular biology, biochemistry and enzymology.  
- Enzyme purification at laboratory scale and characterization of substrate 
specificity, kinetic properties and stability. Extensive screening of alcohols, 
aldehydes and ketones is needed, with particular attention to bulky 
aromatic ketones, since many of the corresponding chiral alcohols are 
important intermediates in the synthesis of pharmaceuticals and 
agrochemicals. 
Following the individuation of the most efficient substrate, it is necessary 
to determine: 
- the optimal parameters for the enzyme oxidation and reduction 
reaction, such as buffer, pH and temperature 
- determination of the kcat/Km values for the more interesting substrates  
-  the enzyme thermophilicity and thermostability and its resistance to 
organic solvents 
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- the optimal reaction conditions to develop an efficient bioreduction 
system for producing chiral alcohols of interest. 
 
Characterization of the crystal structure of the purified proteins by X-
ray diffraction studies  
 
The structural analysis of the enzyme-cofactor-substrate complex allows to 
identify residues involved in the binding of the alcohol and/or ketone and 
in particular those determinants the stereo-preference, to design mutants to 
improve substrate specificity, stereospecificity and enzyme stability. 
(Schlieben et al. 2005; Zhang et al. 2008). The availability of detailed 
structural information has provided guidance on the possible enzyme action 
mechanisms. This work has been performed in close collaboration with Dr. 
Luciana Esposito of IBB, CNR, Naples. 
 
The cofactor regeneration 
The vast majority of dehydrogenases used for ketone reduction require 
nicotinamide cofactors, such as NADH and NADPH that are converted in 
equimolar amounts compared to the substrate. Due to the high costs of 
NAD(P)H, a suitable cofactor regeneration is required (van der Donk and 
Zhao 2003). An efficient bioreduction system requires a simultaneous and 
valid coenzyme-regenerating step and an appropriate reaction engineering 
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technique. To achieve an efficient recycling, two strategies are feasible 
(Fig. 3).  
 
Figure 3. Regeneration of cofactors by (A) coupled-substrate and (B) coupled-enzyme 
strategies. 
 
The most elegant and simple approach makes use of a single enzyme, 
which simultaneously transforms substrate plus co-substrate. A very 
common system consists in using 2-propanol as co-substrate. The latter, 
however, must be applied in large excess to drive the equilibrium into the 
desired direction. As a consequence, these so-called ‘coupled-substrate’ 
systems are commonly impeded by cosubstrate-inhibition. To circumvent 
these drawbacks, cofactor-recycling can be performed by using a second 
(and preferably irreversible) enzymatic reaction, for example using formate 
dehydrogenase or glucose dehydrogenase. 
Formate dehydrogenase (FDH) is a promising enzyme for cofactor 
regeneration, because the substrate formate is very
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product through cofactor regeneration is carbon dioxide, which is volatile 
and makes the reaction irreversible. Glucose dehydrogenase (GDH) can 
also be utilized as a cofactor regeneration enzyme. This enzyme is rather 
inexpensive, highly active, and stable. Since GDH can regenerate both 
NADH and NADPH via glucose oxidation, it could be used with various 
kinds of carbonyl reductases, independent of their cofactor specificities. 
 
Genome sequence analysis of SDRs 
As noted above, a typical SDR is characterized by ~250 residue subunits, a 
Gly-motif in the coenzyme-binding regions and a catalytic triad formed by 
the highly conserved residues Tyr, Lys, Ser (Kallberg et al. 2002). 
Interestingly, analysis of the LB-RADH sequence based on multiple-
sequence alignment with other well-known SDRs had suggested (Kallberg 
et al. 2002) an important role in the aspartate residue (D37) located 18 
amino acids C terminal of the third glycine residue (see Fig. 4). Structural 
studies on the LB-RADH mutant G37D have shown that this residue plays 
a critical role in determining the preference of SDRs for NAD(H) 
(Schlieben et al. 2005). Further evidence of this role is provided by the 
LsADH (Inoue et al. 2006) and PED (Höffken et al. 2006) proteins, both 
being strictly NAD-dependent SDRs possessing an aspartate residue at 
position 37. 
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Thus, SDRs possessing an aspartate residue at position 37 are expected to 
show preference of NAD(H) over NADP(H), the proper being 5 to 6-fold 
less expensive than the latter. This preference as well as an intrinsic 
thermal/long term stability and tolerance of organic solvents are the 
features that make an oxidoreductase more attractive from an application 
perspective (Hummel 1999; Kroutil et al. 2004; Zhu et al. 2006). Therefore, 
our first aim was to identify genes coding for putative oxidoreductases with 
these distinctive features, NAD dependency and structural stability, in the 
genome of thermophilic microorganisms such as Thermus termophilus, 
Sulfolobus acidocaldarius, Thermotoga maritima MSB8, 
Thermoanaerobacter ethanolicus and Bacillus licheniformis. 
 
Next sections deal with: 
i) an applicative utilization of Thermus termophilus ADH 
ii) the complete characterization of two ADHs from Sulfolobus  
    acidocaldarius 
iii) an applicative utilization of Bacillus stearothermophilus ADH. 
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RESULTS and DISCUSSION 
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Asymmetric reduction of α-keto esters with Thermus 
thermophilus NADH dependent carbonyl reductase 
 
 
 
Thermus thermophilus alcohol dehydrogenase (TtADH) 
Perusal of the genome of Thermus thermophilus HB27, an extremely 
thermophilic, halotolerant gram-negative eubacterium (Henne et al. 2004), 
available in the Gene Bank Data Base revealed the presence of one gene 
coding for a putative oxidoreductase. The amino acid sequence (Fig. 4) 
shows an aspartate residue (D37) located 18 amino acids C-terminal of the 
third glycine residue, suggesting that the putative dehydrogenase/reductase 
was expected to display a preference for NAD(H) rather NADP(H).  
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Figure 4. Multiple-sequence alignment of the T. thermophilus ADH (TtADH) and 
ADHs belonging to the SDR family, including Leifsonia sp. strain S749 ADH (LsADH) 
(NCBI accession no. BAD99642), L. brevis ADH (LB-RADH) (PDB code 1ZK4), and 
(S)-1 phenylethanol dehydrogenase from denitrifying bacterial strain EbN1 (PED) (PDB 
code 2EWM). The sequences were aligned using the BioEdit program. Gray shading 
indicates residues highly conserved in the SDR family. The four members of the 
catalytic tetrad are indicated by a black background. The following positions are 
indicated by bold type: the glycine-rich consensus sequence and the sequence motif 
Dhx(cp) that (in all SDRs) have a structural role in coenzyme binding (Kallberg et al. 
2002). The star indicates the major determinant of the coenzyme specificity. The LB-
RADH G37D mutant shows preference for NAD+ over NADP+ (Schlieben et al. 2005). 
 
This prompted us to isolate and study the novel enzyme mainly to 
characterize its substrate specificity and stereoselectivity. The purification 
to homogeneity and the complete characterization of the T. thermophilus 
ADH recombinant form (TtADH) appeared in a paper prior to this doctoral 
thesis (Pennacchio et al. 2008).  
Briefly, TtADH is a tetrameric enzyme consisting of identical 26,961-Da 
subunits composed of 256 amino acids. The enzyme has remarkable 
thermophilicity and thermal stability, displaying activity at temperatures up 
  
 31
to ~73°C and a 30-min half-inactivation temperature of ~90°C, as well as 
good tolerance to common organic solvents. TtADH has a strict 
requirement for NAD(H) as the coenzyme, a poor activity on aromatic 
alcohols and aldehydes and a preference for reduction of aromatic ketones 
and -keto esters.  
 
Two interesting substrates of TtADH 
The enzyme was found to catalyze the reduction of methyl benzoylformate 
(MBF) to methyl (R)-mandelate (MM) and methyl o-chlorobenzoylformate 
(ClMBF) to  methyl (R)-o-chloromandelate (ClMM), two valuable 
synthons used in organic synthesis.  
 
Cl
 
R = H Methyl Benzoylformate (MBF) 
 
R = H Methyl (R)-mandelate (MM) 
R = Cl Methyl o-chlorobenzoylformate (ClMBF) R = Cl Methyl (R)-o-chloromandelate (ClMM) 
 
O-protected MM is used as an intermediate for the synthesis of 
pharmaceuticals (Kobayashi et al. 1990; Pousset et al. 2001) and ClMM is 
an intermediate for the anti-thrombotic agent, (S)-clopidogrel, 
  
 32
commercialized under the brand name Plavix (clopidogrel sulfate) 
(Bousquet and Musolino 1999).  
These interesting applicative properties prompted us to develop a system 
for the enzymatic synthesis of MM and ClMM by TtADH evaluating the 
use of glucose dehydrogenase as well as BsADH for cofactor regeneration 
as Scheme 2 shows:  
 
 
 
The development includes a) the determination of the optimal reaction time 
and substrate concentration in the absence and presence of organic solvents 
and b) the choice of the suitable alcohol as co-substrate for the 
TtADH/BsADH system. 
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Enzymatic synthesis of MM and ClMM by TtADH using glucose 
dehydrogenase for cofactor regeneration 
 
Glucose dehydrogenase from Thermoplasma acidophilum (TaGDH), a 
thermophilic and stable enzyme possessing dual cofactor-specificity (John 
et al. 1994) was utilized for the in situ NADH-regeneration system together 
with glucose as the hydride source (Scheme 2). Biosynthesis experiments 
in analytical scale were undertaken to combine the optimum values of pH, 
temperature, substrate concentration, stirring speed, and reaction time.  
 
Optimal pH 
Previous studies showed that the optimal pH for the reduction reaction 
catalyzed by TtADH is approximately 6.0 (Pennacchio et al. 2008) and that 
for glucose oxidation catalysed by TaGDH is 7.0 (Woodward et al. 2000). 
Due to the instability of the reduced cofactor under acidic conditions, 
neutral pH was chosen as a compromise taking into account cofactor 
stability and TtADH activity at suboptimal pH. 
 
Optimal reaction time and temperature 
TaGDH retains full catalytic activity after 9 h at 55°C (Smith et al. 1989), 
while TtADH is highly efficient and selective at 50°C (Pennacchio et al. 
2008). To establish the optimal reaction time the conversion of MBF was 
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carried out at 50°C, at low substrate concentration (1 g L–1, 6.2 mM) in 
aqueous solution and by letting the reactions proceed for 1, 3, 6 and 24 h. 
Fig. 5 shows the conversion of MBF proceeded in 99% after 6 h, affording 
the (R)-α-hydroxy ester MM with 95% ee.  
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Figure 5. Time course of the bioreduction of MBF by TtADH. The reactions were 
carried out at 50°C in 50 mM sodium phosphate, pH 7.0, 100 mM KCl and NADH 
regeneration system of TaGDH and glucose. Reaction volume, 0.2 mL; TtADH and 
TaGDH 25 and 5.5 µg, respectively; NAD+, 1.0 mM; MBF, 1.0 g L–1; glucose, 50 mM. 
The reactions were stopped by addition of ethyl acetate at the times indicated. The dried 
extracts were analysed by chiral HPLC and the relative conversion calculated as the 
area of alcohol products divided by the total area. 
 
The degree of conversion and ee of the biotransformation was unchanged at 
reaction times as long as 24 h. The high conversion is noteworthy, 
considering that TaGDH has a marked preference for NADP(H) over 
NAD(H) (John et al. 1994). 
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Optimal substrate concentration  
Bioconversions were then carried out using increasingly higher 
concentrations of MBF for a reaction time of 24 h. The conversion 
proceeded with ~99% at MBF to 10 g L–1 MBF, but decreased to ca. 10% 
and ca. 1% yields at 30 and 50 g L–1 substrate, respectively. However, the 
ee of MM was 95% over the whole range of concentrations for MBF that 
were examined (see Fig. 6). The decrease in conversion could be due to a 
decrease in solubility of the substrate, enzyme inactivation by substrate or 
product, or both factors.  
[MBF]    (g L-1)
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Figure 6. Production of MM at different MBF concentrations. The reactions were 
carried out at 50°C in 50 mM sodium phosphate, pH 7.0, 100 mM KCl and NADH 
regeneration system of TaGDH and glucose. Reaction volume, 1 mL; TtADH and 
TaGDH 25 and 5.5 µg, respectively; NAD+, 1.0 mM; MBF, 1.0 g L–1; glucose, 50 mM. 
The reactions were stopped by addition of ethyl acetate after 24 h of reaction. The dried 
extracts were analysed by chiral HPLC and the relative conversion calculated as the 
area of alcohol products divided by the total area. 
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TtADH stability in organic solvent 
The next step was to develop a suitable solvent system to improve 
bioconversions at higher substrate concentrations. TtADH possesses a 
remarkable tolerance to common organic solvents. Indeed, it even showed 
a significant increase in activity in the presence of various organic solvents, 
reaching 150% and 180% of the initial value with 5% v/v acetonitrile and 
10% v/v 2-propanol, respectively, after 24 h of incubation at 50°C and 
182% with 10% v/v hexane after 65 h at 25°C (see Pennacchio et al. 2008). 
 
TaADH stability in organic solvent 
The stability of the archaeabacterial glucose dehydrogenase in the presence 
of organic solvents was investigated to evaluate its tolerance to organic 
solvents (Fig. 7). TaGDH was inactivated by 34% and 28% following 24 h 
incubation at 50°C, in the absence and presence of 20% v/v hexane, 
respectively. Moreover, the enzyme was inactivated by over 50% in the 
presence of 5% v/v and 10% v/v DMSO, 10% v/v acetonitrile or 10% v/v 
methanol. However, incubation in the presence of 5% and 10% v/v 2-
propanol, 5% v/v methanol or 5% v/v acetonitrile resulted in activities that 
were similar to those measured in aqueous buffer after 6 h and 24 h. 
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Figure 7. Effects of organic solvents on TaGDH. Samples of enzyme (0.025 mg mL–1) 
in 50 mM sodium phosphate, pH 7.0 were incubated at 50°C in the absence and 
presence of the organic solvents at the indicated concentrations, and assays were 
performed after 6 h and 24 h. The activity assays were performed as described in 
Material and Methods using glucose as the substrate. The data obtained in the absence 
and presence of organic solvents are expressed as percentage activity relative to the 
value determined prior to incubation. 
 
Bioconversions at higher substrate concentrations 
Bioconversions were carried out at different concentrations of MBF in the 
presence of acetonitrile or hexane at concentrations of 5% and 20% v/v, 
respectively; these concentrations fulfilled the majority of the criteria for a 
solvent system in which both enzymes retained activity. As shown in Fig. 
8, the presence of water-miscible or immiscible organic solvents did not 
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improve conversion at concentrations of MBF higher than 10 g L–1, since 
the profiles of the conversion with acetonitrile and hexane were similar to 
those obtained in aqueous buffer (Fig. 6). 
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Figure 8. Production of MM at different MBF concentrations. The reactions were 
carried out for 24 h at 50°C under the same conditions as for Fig. 6 at increasing 
substrate concentrations and in the presence of 5% v/v acetonitrile and 20% v/v hexane. 
 
Nevertheless, the good levels of conversion obtained between 1 and 10  
g L–1 substrate was accompanied by a slight decrease in enantioselectivity 
in the presence of acetonitrile (ee = 85%–89%) as well as in the presence of 
hexane (ee = 92–93%) compared to the 95% ee obtained in aqueous buffer. 
The decrease in enantioselectivity could be related to the solvent-mediated 
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enhancement of catalysis as a result of increased flexibility of the enzyme 
active site (Pennacchio et al. 2008).  
 
Optimal conditions for bioconversions at lab-scale  
In light of our findings related to enantioselectivity and concentration, 
optimum conditions for the bioconversion of MBF as well as ClMBF were 
determined to involve a temperature of 50°C, substrate concentrations up to 
10 g L–1, in the presence of 1 mM NAD+ in pH 7.0 aqueous buffer. 
Table 2 summarizes the results of a study carried out for the two α-hydroxy 
esters.  
 
Table 2. Reduction of MBF and ClMBF to MM and ClMM with TtADH by 
the TaGDH/glucose-NADH regeneration system [a] 
 
Entry MBF 
(mg) 
[MBF]  
(g L–1) 
TtADH 
(mg mL–1) 
TaGDH 
(mg mL–1) 
Conversion[b] 
(%) 
ee
[b]
 
(%) 
1 100 10 0.05 0.010 100 (74) [d] 95 
2 [c] 100 2 0.10 0.010 78   (77) [d] 96 
 ClMBF 
(mg) 
[ClMBF]  
(g L–1) 
    
3 100 10 0.125 0.0275 28   (nd) [d] 88 
4 100 2 0.100 0.020 96   (86) [d] 93 
5 100 5 0.125 0.0275 100 (62) [d] 95 
[a] The reactions were carried out for 24 h at 50°C. 
[b] Determined by HPLC [Chiralcel OD-H, hexane/i-PrOH [(9:1)]. 
[c] The reaction was carried out in 6 h. 
[d] Isolated yield in parentheses. nd, not determined. 
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The bioreduction of 100 mg of MBF at 50°C for 24 h gave 74 mg of  MM 
with ee = 95% (Table 2, entry 1). The same reaction carried out in 6 h with 
a 5-fold lower substrate and 2-fold higher TtADH concentrations yielded 
slightly better results (Table 2, entry 2). However, the conversion and 
optical purity of  ClMM were somewhat lower when the concentration of  
ClMBF was 10 g L–1 (Table 2, entry 3). Nevertheless, the bioreduction of 
100 mg of ClMBF gave 86 and 62 mg of ClMM with similar ee (Table 2, 
entries 4 and 5) at substrate concentrations of 2 and 5 g L–1, respectively. 
This suggests that greater insolubility of the halogenated keto ester and/or 
enzyme inactivation alters the efficiency of the biotransformation. It is 
noteworthy that, although the affinities of the two substrates are quite 
different, the presence of the halogen in substrate ClMBF did not affect 
TtADH enantioselectivity. 
 
Enzymatic synthesis of MM and ClMM by TtADH using BsADH for 
cofactor regeneration 
 
Early bioconversion processes performed to establish TtADH 
enantioselectivity were carried out on analytical scale by way of an in situ 
NADH-recycling system involving a second thermophilic NAD-dependent 
ADH, the recombinant ADH from Bacillus stearothermophilus (BsADH) 
(Pennacchio et al. 2008). The bacillary enzyme is active with 2-propanol 
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which was therefore used as both co-solvent and substrate. The enzyme is 
inactive on aliphatic and aromatic ketones, including the carbonyl 
substrates of TtADH and the corresponding alcohols. However, TtADH 
does not accept 2-propanol or acetone as substrates. These features allowed 
the reaction to proceed almost to completion for reduction of 3 mg of MBF 
to MM with 99% conversion and ee = 91%, in 24 h at 50°C, and in the 
presence of 2% v/v 2-propanol (Pennacchio et al. 2008).  
 
Bioconversions at lab-scale  
The scaled-up bioreduction of MBF involving 100 mg of substrate was 
performed by increasing the amount of 2-propanol to 4% v/v and using 
different enzyme concentrations. The data summarized in Table 3 indicate  
 
Table 3. Asymmetric reduction of MBF with TtADH by the BsADH/2 propanol-  
NADH regeneration system [a]    
  
Entry TtADH 
(mg mL–1) 
BsADH 
(mg mL–1) 
Time 
(h) 
2-propanol 
(% v/v) 
Conversion [b] 
(%) 
ee 
[b]
 
(%) 
1 0.050 0.010 6 4 81 84 
2 0.050 0.010 24 4 97 86 
3 0.265 0.024 6 4 96 87 
[a] Conditions: MBF concentration, 10 g L–1; TtADH and BsADH at the indicated   
     concentrations; 1 mM NAD+; buffer, 0.1 M sodium phosphate pH 7.0, 0.1 M 
     KCl, 5 mM 2-mercaptoethanol. Reaction volume, 10 mL. Temperature, 50°C.  
[b] Determined by HPLC [Chiralcel OD-H, hexane/i-PrOH [(9:1)]. 
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that the improved conversion was obtained either in a short reaction time (6 
h) using higher amounts of the two enzymes (Table 3, entry 3) or using 
lower amounts of enzymes at a reaction time which was four times longer 
(Table 3, entry 2). 
Notably, the yields of 96–97% were similar to those obtained from 
bioreductions using 3 mg substrate (Pennacchio et al 2008), but with a 
lower optical purity (86–87% ee relative to 91% ee), suggesting that the 
change in TtADH selectivity could be related to 2-propanol concentrations. 
 
Choosing the most suitable alcohol 
In addition to 2-propanol (kcat/Km = 9 s–1 mM–1), BsADH oxidizes other 
alcohols with even greater efficiency. Examples include ethanol (kcat/Km = 
64 s–1 mM–1), 1-propanol (286 s–1 mM–1), 1-butanol (437 s–1 mM–1), 1-
pentanol (64 s–1 mM–1), and 1-hexanol (64 s–1 mM–1) (Raia, unpublished 
data) and these were therefore tested as alternative hydride sources for 
NADH recycling. Moreover, these alcohols and their respective aldehydes 
are not substrates of TtADH (Pennacchio et al. 2008). Thus, only the 
cofactor is the co-substrate of TtADH and BsADH.  
Bioreductions of 100 mg of MBF were carried out in the presence of each 
alcohol at a concentration of 4% v/v, which corresponds to 700 mM for 
ethanol down to 310 mM for 1-hexanol. All values were over-saturating for 
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the bacillary ADH. The data obtained were plotted against the respective 
logP values to correlate conversions and the TtADH enantioselectivity with 
the hydrophobicity of the alcohol added (Fig. 9).  
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Figure 9. Effect of the BsADH alcohol substrate on the enantioselectivity and 
efficiency of the reduction catalysed by TtADH. 1, ethanol (log P = –0.24); 2, 2- 
propanol (0.07); 3, 1-propanol (0.28); 4, 1-butanol (0.8); 5, 1-pentanol (1.3); 6, 1-
hexanol (1.8). The reactions were carried out for 24 h at 50°C under the same conditions 
as for Table 3 in the presence of 4% v/v alcohol. TtADH and BsADH concentrations, 
0.050 and 0.010 mg mL–1, respectively; vol = 10 mL. Data for 2- propanol were from 
Table 3, obtained after 24 hours of reaction (entry 2). Error limit, 2% of the stated 
values. 
 
The TtADH enantioselectivity decreased as the hydrophobicity of the 
medium increased. However, the level of conversion remained high and 
near constant for all of the alcohols tested, emphasizing the versatility and 
high efficiency of the BsADH/alcohol substrate system in recycling the 
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reduced cofactor. An increase in conversion rate with increasing log P with 
no effect on enantioselectivity was recently reported for the 2-octanone to 
(R)-2-octanol reduction with Oenococcu oeni cells in a biphasic system 
(Hu and Xu 2006). Moreover, Lactobacillus brevis ADH enantioselectivity 
was recently shown not to be altered by the presence of an organic phase 
(Villela Filho et al. 2003). Instead, Thermoanaerobium brockii ADH 
enantioselectivity was seen to increase proportionally to increasing water 
composition (Jönsson et al. 1999). In general terms, the stereoselectivity of 
enzymes decreased as solvent hydrophobicity increased (Carrea and Riva 
2000) and enantiofacial selectivity was also significantly affected by the 
reaction medium (Klibanov 2001). Although the examples mentioned 
describe biphasic systems, including high concentrations of an apolar 
solvent, the effect of relatively low concentrations of polar protic solvents 
on the TtADH enantiofacial selectivity is rather remarkable. Docking 
calculations using the TtADH structure explain the selective formation of 
the methyl (R)-mandelate (Pennacchio et al. 2010b) by showing that the 
methyl benzoylformate molecule assumes the lowest energy orientation by 
fitting the phenyl ring into a hydrophobic pocket, with the two carbonyl 
groups staggered by about 78° and the methoxy group pointing toward the 
carboxyamide group of the cofactor. Moreover, the docking analysis 
showed that the keto ester molecule can also assume another conformation,  
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less energetically favourable compared to that described above, which has 
the opposite face of the carbonyl group directed to the nicotinamide ring, 
and therefore leading to the (S)-enantiomer of the alcohol product. 
Importantly, there is no major steric constraint preventing the positioning 
of this alternative conformation in the enzyme active site (Pennacchio et al. 
2010b). A change in polarity occurring in the active site may induce a 
structural rearrangement that facilitates the positioning of this alternative 
conformation. Since the TtADH/BsADH system showed higher 
enantioselectivity with ethanol than with 2-propanol, the next step was to 
examine the synthesis of MM using concentrations of ethanol lower than 
4% v/v (Table 4).  
 
 
 
 
 
 
 
 
[a] Conditions reaction and chiral analysis as in Table 1. Amount of MBF = 100 mg  
   MBF concentration, 10 g L–1, except for # 6: 2 g L–1. Values in parentheses refer 
   to data obtained with 2 mM NAD+. nd, not determined. 
 
Table 4. Asymmetric reduction of MBF with the TtADH/BsADH system at 
different ethanol and cofactor concentrations [a]  
 
Entry Ethanol 
(% v/v) 
NAD+ 
(mM) 
TtADH 
(mg mL–1) 
BsADH 
(mg mL–1) 
Conversion 
(%) 
ee 
(%) 
Isolated 
yield 
(%) 
1 0.6 1 (2) 0.05 0.01 60 (89) 90 (90) nd 
2 1 1 (2) 0.05 0.01 79 (98) 89 (92) nd 
3 2 1 (2) 0.05 0.01 92 (98) 90 (93) nd 
4 3 1 (2) 0.05 0.01 91 (98) 92 (92) nd 
5 4 1 (2) 0.05 0.01 91 (99) 91 (93) nd 
6 4 2 0.10 0.02 99 94 81 
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The keto ester reduction was limited by the cofactor recycling rate when 
the ethanol percentage was 0.6% or 1% v/v and the cofactor concentration 
was 1 mM (Table 4, entries 1 and 2). This concentration is much lower 
than the cofactor Km (13±2 mM) and is therefore far below that required for 
saturation of the BsADH active sites. However, by doubling the cofactor 
concentration, the conversion increased from 60 to 89% (Table 4, entry 1) 
and from 79 to 98% (Table 4, entry 2) in the presence of 0.6% and 1% v/v 
ethanol, respectively. Conditions employing 4% v/v ethanol and 2 mM 
NAD+ (Table 4, entries 5 and 6) and a substrate concentration of 2 g L–1 (as 
in Table 2, entry 2) were shown to be ideal for achieving asymmetric 
reduction of 100 mg of MBF with 81% isolated yield and ee = 94% (Table 
4, entry 6). The bioconversion of ClMBF to ClMM occurred with the same 
enantioselectivity as the non-halogenated compound and with good 
productivity (Table 5).  
 
Table 5. Reduction of ClMBF to ClMM with TtADH by the BsADH /ethanol - 
NADH regeneration system [a] 
 
Entry ClMBF 
(mg) 
[ClMBF] 
(g L–1) 
TtADH 
(mg mL–1) 
BsADH 
(mg mL–1) 
Conversion[b] 
(%) 
ee
[b]
 
(%) 
 
1 1 1 0.05 0.01 100 91 
2 2 2 0.05 0.01 100 92 
3 100 2 0.10 0.02 98 (78) [c] 92 
[a] The reactions were carried out for 24 h at 50°C. Ethanol, 4% v/v. 
[b] Determined by HPLC [Chiralcel OD-H, hexane/i-PrOH [(9:1)]. 
[c] Isolated yield in parentheses. 
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Using relatively low substrate concentrations 78 mg of ClMM (ee = 92%) 
was obtained from 100 mg of ClMBF in 24 h at 50°C (Table 5, entry 3). As 
in the case for the TtADH/TaGDH system (Table 2, entry 3) the substrate 
concentration of 2 g L–1 was found to be optimal for scaling up production 
of ClMM. However, the formation of the more reactive acetaldehyde could 
limit the use of ethanol as a regeneration reductant. Nevertheless, new 
applications for ethanol as a tunable nicotinamide reductant under four-
electron redox conditions for the chemoenzymatic synthesis of important 
synthons (Broussy et al. 2009), as well as solvent and reductant in the 
enantioselective synthesis of (S)-profens using Sulfolobus solfataricus 
ADH (Friest et al. 2010) and (2S)-2-arylpropanols using horse liver and 
yeast ADHs (Galletti et al. 2010) have been recently reported. 
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Conclusion 
The enzymatic synthesis of methyl (R)-mandelate (MM) and methyl (R)-o-
chloromandelate (ClMM), two important pharmaceutical building blocks, 
has been developed in a one-phase system, using a carbonyl reductase and 
two different dehydrogenases to recycle the NADH. The two regeneration 
modes gave similar yields and optical purities. BsADH displayed two 
distinct advantages: feasibility of purification and high efficiency at 
suboptimal pH. For the TaGDH method, the hydride source was glucose, 
which constitutes cheap biomass whereas for the BsADH method, ethanol 
was the cheap sacrificial substrate. Both methods are characterized by 
favourable thermodynamics since alcohol/aldehyde, and glucose/gluconic 
acid do not interfere with the synthesis reaction. Only a few examples are 
known for enzyme-coupled cofactor regeneration involving a second ADH 
(Goldberg et al. 2007) and the present study represents a successful 
application of the bacillary ADH. 
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Two short-chain NAD(H)-dependent 
dehydrogenase/reductase from Sulfolobus 
acidocaldarius: SaADH and SaADH2. 
 
 
 
Two amino acid sequences with typical features of the SDRs were found in 
the genome of S. acidocaldarius, an aerobic thermoacidophilic crenarcheon 
which grows optimally at 80°C and pH 2 (Chen et al. 2005). Both the 
putative archaeal oxidoreductases were expected to be NAD dependent 
based on the presence of an Asp residue at position 42, and a glutamic acid 
residue at position 39 of the first and second sequence, respectively. 
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Biochemical characterization of a recombinant short-
chain NAD(H)-dependent dehydrogenase/reductase 
from Sulfolobus acidocaldarius 
 
The first gene, saadh, encoding a putative NAD(H)-dependent 
oxidoreductase has been heterologously overexpressed in Escherichia coli, 
and the resulting protein (SaADH) purified to homogeneity and 
characterized in terms of substrate specificity, kinetics and stability as well 
as enantioselectivity. 
 
Expression and protein purification 
Analysis of the Sulfolobus acidocaldarius genome (Chen et al. 2005) for 
genes encoding short-chain ADHs resulted in identification of a putative 
oxidoreductase gene. The oxidoreductase protein, named SaADH, was 
expected to be NAD(H)-dependent on the basis of the presence of an 
aspartic residue at position 42, whose critical role in determining the 
preference for NAD(H) (Kallberg et al. 2002) has been shown through 
kinetic and structural studies of the LB-RADH G37D mutant (Schlieben et 
al. 2005), and recently supported by kinetic studies (Pennacchio et al. 
2008) and structural characterization of TtADH (Asada et al. 2009). 
SaADH is a 28,978-Da protein whose sequence shows the greatest identity 
to four typical SDRs, LB-RADH (30% identity), LsADH (29%), PED 
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(28%), and TtADH (27%), as well as the archaeal AdhA (25% identity). 
The saadh gene was successfully expressed in E. coli cells, yielding an 
active enzyme accounting for more than 20% of the total protein content of 
the cell extract (Table 6).  
 
Table 6. Purification of recombinant SaADH [a] 
Step Total 
protein 
(mg) 
Total 
activity 
(U) 
Specific 
activity 
(U/mg) 
Yield 
(%) 
Purification 
(fold) 
 
Crude extract 
 
294 
 
750 
 
2.5 
 
100 
 
1 
 
Thermal step 
 
184 
 
618 
 
3.3 
 
82.4 
 
1.3 
 
DEAE FF 
 
119 
 
578 
 
4.8 
 
77.0 
 
1.9 
 
Gel filtration 
 
68 
 
452 
 
6.6 
 
60.3 
 
2.6 
[a]
 The data are for a 2-liter culture. Activities were measured at 65°C as 
described in Materials and Methods, using cycloheptanol as substrate. 
 
Host protein precipitation at 75°C was found to be the most effective 
purification step. An overall purification of 2.6-fold was achieved from 
crude, cell-free extracts with an overall yield of 60%. The enzyme was 
shown to be homogeneous by denaturing and non-denaturing PAGE (data 
not shown). Protein separation by SDS-PAGE resulted in a single band 
corresponding to a molecular mass of ~30 kDa (see below). Gel filtration 
performed in 50 mM Tris–HCl buffer, pH 9.0 containing 150 mM NaCl 
yielded a profile consisting of a single peak corresponding to molecular 
mass ~65 kDa (data not shown). The quaternary structure of SaADH was 
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further investigated by chemical crosslinking using dimethyladipimate 
(DMA, N–N distance 8.6 Å) and dimethylsuberimidate (DMS, N–N 
distance 11.0 Å) as bifunctional reagents. SDS-PAGE of the DMAcross- 
linked enzyme resulted in the appearance of four bands decreasing in 
intensity from monomer to tetramer (Fig. 10). 
 
 
Figure 10. SDS-PAGE analysis of cross-linked SaADH. Lanes 1 and 5 DMS- and 
DMA-cross-linked and denatured enzyme, respectively. Lanes 2 and 6 non-cross-linked 
denatured enzyme. Lanes 3 and 7 DMS- and DMA-cross-linked and denatured aldolase, 
respectively. Lanes 4 and 6 non-cross-linked denatured aldolase. The kDa values refer 
to Mr of monomer, dimer, trimer, and tetramer of cross-linked aldolase, used as 
molecular mass markers. I, II, III, and IV indicate the monomer, dimer, trimer, and 
tetramer of DMS-cross-linked SaADH. Cross-linking reaction and SDS-PAGE were 
carried out as described in Materials and Methods. 
 
However, the longer cross-linking reagent, DMS, resulted in a pattern 
predominantly consisting of crosslinked tetramer and smaller amounts of 
the other species (Fig. 10). These data suggest that SaADH has a tetrameric 
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structure which adopts a more compact structure in the presence of salt, 
resulting in greater permeation into the packing pores of the gel matrix. 
However, it is not excluded that a tetramer to dimer dissociation occurs in 
the presence of relatively high salt concentration. The molecular mass of 
the subunit determined by ESIMS analysis proved to be 28,978.0 Da 
(average mass), in agreement with the theoretical value of the sequence. 
 
Optimal pH and thermophilicity 
Fig. 11 shows the pH dependence of SaADH in the reduction and oxidation 
reactions.  
 
Figure 11. SaADH activity as a function of pH in the reduction and oxidation reactions. 
The following 50 mM buffer solutions were used: sodium acetate (open circles), MES 
(open triangles), and sodium phosphate (open square) in the reduction reaction, and 
sodium phosphate (filled circles), Tris–HCl (filled triangle), and glycine–NaOH (filled 
squares) in the oxidation reaction. The mixture for the reduction reaction contained 25 
mM methyl benzoylformate and 0.1 mM NADH, and the mixture for the oxidation 
reaction contained 25 mM cycloheptanol and 5 mM NAD+. The assays were performed 
at 65°C under the conditions described in Materials and Methods. 
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The SaADH activity was found to be closely dependent on pH in the 
reduction reaction, displaying a narrow peak of maximum activity at 
approximately pH 5.1. The oxidation reaction showed a less marked 
dependence on pH, displaying a peak with a maximum at around pH 8.2. 
The effect of temperature on SaADH activity is shown in Fig. 12.  
 
 
Figure 12. Temperature dependence of the SaADH activity. The assay was carried out 
as described in Materials and Methods, using cycloheptanol as the substrate. The inset 
shows the Arrhenius plot from the same data. The value of the activation energy was 
72.8 ± 2.0 kJ mol-1. 
 
The reaction rate increases up to 75°C and then decreases rapidly due to 
thermal inactivation. This optimal temperature value is similar to that of 
TtADH (73°C) (Pennacchio et al. 2008
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medium-chain, zinc-containing ADHs such as SsADH (88°C) (Raia et al. 
2001) and TbADH (85°C) (Korkhin et al. 1998), and significantly lower 
than that of Pyrococcus furiosus aldo–keto reductase (100°C) (Machielsen 
et al. 2006). The activation energy for oxidation is 72.8 ± 2.0 kJ mol-1, 
which is higher than that determined for TtADH (62.9 ± 2.6 kJ mol-1) 
(Pennacchio et al. 2008) or SsADH (46.7 kJ mol-1) (Raia et al. 2001), and 
lower than that reported for TbADH (94.1 kJ mol-1) (Korkhin et al. 1998). 
 
Coenzyme and substrate specificity 
The enzyme showed no activity with NADP(H) and full activity with 
NAD(H). This coenzyme preference further supports the evidence that an 
aspartate residue at position 37 of an SDR enzyme (numbering of LB-
RADH) plays a critical role in discriminating NAD(H) from NADP(H) 
as discussed above. The specificity of SaADH for various alcohols, 
aldehydes and ketones was examined (Table 7). The enzyme showed no 
activity on aliphatic linear and branched alcohols (not shown), except for a 
poor activity on 2-propyn-1-ol, 3-methyl-1-butanol and 2-pentanol; 
however, it showed a discrete activity on aliphatic cyclic and bicyclic 
alcohols. Benzyl alcohol and 4-bromobenzyl alcohol were not found to be 
substrates. In contrast, in view of the great influence that the strong 
electron-donating methoxy group exerts on the para 
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[a]
 The assays were performed using 1 mL of mixture containing 10 mM alcohol and 5  
     mM NAD+ in 25 mM sodium phosphate, pH 8.0, at 65°C for 1 min. Relative rates 
     were calculated by setting the activity to be 100 for (S)-1-indanol. 
[b]
 Substrates were dissolved in 100% 2-propanol. 
[c]
 Substrate was dissolved in 100% acetonitrile. 
[d]
 The assays were performed using 1 mL of mixture containing 10 mM carbonyl  
     compound and 0.1 mM NADH in 37.5 mM MES-NaOH, pH 5.5, at 65°C for 1 min.  
     Substrates were dissolved in 2-propanol and added to the reaction mixture (10 mM  
     in 2% [vol/vol] 2-propanol). The percent values refer to 2,2,2-trifluoroacetophenone  
    for ketones, and to methyl benzoylformate for ketoesters.  
[e]
 Substrate concentration, 1 mM; solvent, acetonitrile; the enzyme was present at a  
     seven-fold lower concentration. 
Table 7. Substrate specificity of SaADH in the oxidation and reduction reactions  
 
Substrate Relative 
activity 
(%) 
Substrate Relative 
activity 
(%) 
Alcohols [a]  Ketones [d]  
  
 
 
2-Propyn-1-ol 6 Cyclohexanone 0 
3-Methyl-1-butanol 4 2-Methylcyclohexanone 0 
(±)-2-Pentanol 5 3-Methylcyclohexanone 29 
(S)-2-Pentanol 11 4-Methylcyclohexanone 0 
(R)-2-Pentanol 0 2,6-Dimethylcyclohexanone 0 
Cyclopentanol 5 Cycloheptanone 0 
Cyclohexanol 8 1-Decalone 14 
Cycloheptanol 37 Acetophenone 0 
Cyclohexylmethanol [b] 0 2,2,2-Trifluoroacetophenone 100 
2-Cyclohexylethanol 0 1-Indanone 0 
3-Methylcyclohexanol[b] 14 α-Tetralone 0 
3-Cyclohexyl-1-propanol[b] 0 1-phenyl-1,2-propanedione 70 
cis-Decahydro-1-naphthol 11 Isatin [e] 300 
Benzyl alcohol 0 2-Acetonaphthone 0 
2-Methoxybenzyl alcohol 0   
3-Methoxybenzyl alcohol 0 Keto esters  [d]  
4-Methoxybenzyl alcohol 5   
(R,S)-1-Phenylethanol[b] 6 Ethyl pyruvate 43 
(S)-(−)-1-Phenylethanol 8 Methyl benzoylformate  100 
(R)-(+)-1-Phenylethanol 0 Methyl o-chlorobenzoylformate 160 
(±)-1-Phenyl-1-propanol[b] 8 Ethyl benzoylformate 88 
1-(1-Naphthyl)ethanol 5 Ethyl 4-chloroacetoacetate 27 
(±)-1-(2-Naphthyl)ethanol 6   
(R)-1-(2-Naphthyl)ethanol 5   
(S)-1-(2-Naphthyl)ethanol 5   
(R)-3-Chloro-1-phenyl-1-propanol 5   
(R)-1-Indanol[c] 62   
(S)-1-Indanol[c] 100   
(R)-α-Tetralol[c] 58   
(S)-α-Tetralol[c] 12   
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ring, only the 4-methoxybenzyl alcohol was found to be an active substrate. 
(S)-1-Phenylethanol was also found to be an active substrate, whereas the S 
and R enantiomers of α-(trifluoromethyl) benzyl alcohol and methyl and 
ethyl mandelates showed no apparent activity with SaADH (data not 
shown). Moreover, the enzyme showed relatively poor activity on (±)-1-
phenyl-1-propanol, 1-(1-naphthyl)ethanol and the two enantiomers of 1-(2-
naphthyl)ethanol. However, SaADH showed highest activity with 1-
indanol and α-tetralol (Table 7). The enzyme was not active on aliphatic 
and aromatic aldehydes, and on aliphatic linear, branched and cyclic 
ketones (data not shown) except for 3-methylcyclohexanone (Table 7). 
However, the enzyme showed a relatively high reduction rate with isatin, 
2,2,2-trifluoroacetophenone, and with an aryl diketone such as 1-phenyl-
1,2-propanedione, and a bicyclic ketone such as 1-decalone (Table 7). The 
electronic factor accounts for the discrete activity measured with (S)-1-
phenylethanol and 2,2,2-trifluoroacetophenone, as compared to the 
apparent catalytic inactivity observed with acetophenone and (S)-α-
(trifluoromethyl)benzyl alcohol. In fact, although the CF3 group is 
sterically more demanding than the CH3 group (van der Waals volume 
= 42.7 and 24.5 Ǻ3, respectively) (Zhao et al. 2003), the electron-
withdrawing character of fluorine favours hydride transfer, inductively 
decreasing electron density at the acceptor carbon C1. It is noteworthy that 
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SaADH proved to be very effective in reducing aliphatic and aryl α-keto 
esters, halogenated aryl α-keto esters, and halogenated β-keto esters (Table 
7). These data show that SaADH is a strictly NAD(H)-dependent 
oxidoreductase that has discrete substrate specificity. As such, SaADH is 
more similar to the thermophilic TtADH (Pennacchio et al. 2008), than to 
the three SDR superfamily mesophilic ADHs (i.e., LsADH, LB-RADH, 
and PED) which are active on a variety of aliphatic as well as aromatic 
alcohols, ketones, diketones and keto esters. 
 
Kinetic studies 
The kinetic parameters of SaADH determined for the most active substrates 
are shown in Table 8. Based on the specificity constant (kcat/Km), this 
enzyme shows a fivefold greater preference for (R)- than (S)-α-tetralol, but 
a similar preference for the enantiomers of 1-indanol. (R)- and (S)-1-(2-
naphthyl)ethanol are very poor substrates and display similar specificity 
constants. Alicyclic alcohols such as 3-methylcyclohexanol, cycloheptanol 
and cis-decahydro-1-naphthol were oxidized with relatively low efficiency. 
In the reduction reaction, isatin was preferred more than methyl and ethyl 
benzoylformate, and the halogenated acetophenones as well as the aryl 
diketone 1-phenyl-1,2-propanedione. It is noteworthy that a chlorine 
substituent at position 2 of the phenyl ring of methyl benzoylformate  
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Table 8 Steady-state kinetic constants of SaADH [a] 
Substrate kcat 
(s–1) 
Km 
(mM) 
kcat/Km 
(s–1 mM–1) 
3-Methylcylohexanol 3.4 ± 0.2 9.9 ± 0.5 0.34 
Cyclohepthanol 4.4 ± 0.1 9.3 ± 0.3 0.47 
(±)-1-Indanol 6.6 ± 0.2 2.30 ± 0.02 2.86 
(R)-Indanol 7.1 ± 0.2 2.39 ± 0.01 2.98 
(S)-Indanol 13.7 ± 0.4 6.4 ± 0.3 2.14 
cis-Decahydro-1-naphthol 0.98 ± 0.04 4.2 ± 0.3 0.23 
α-Tetralol 1.2 ± 0.1 0.48 ± 0.09 2.5 
(R)-α-Tetralol 13.5 ± 0.5 1.28 ± 0.03 10.5 
(S)-α-Tetralol 2.1 ± 0.2 1.05 ± 0.08 2.0 
(±)-1-(2-naphthyl)ethanol 0.43 ± 0.01 3.7 ± 0.4 0.11 
(R)-(+)-1-(2-naphthyl)ethanol 0.54 ± 0.06 5.3 ± 0.7 0.10 
(S)- (̶ )-1-(2-naphthyl)ethanol 0.48 ± 0.01 5.4 ± 0.5 0.09 
NAD+  3.7 ± 0.1 0.44 ± 0.04 8.4 
3-Methylcyclohexanone 3.8 ± 0.03 66.0 ± 3.1 0.06 
2,2,2-Trifluoroacetophenone 10.0 ± 0.6 23.5 ± 1.3 0.42 
1-Phenyl-1,2-propanedione 3.1 ± 0.3 12.1 ± 2.2 0.25 
Methyl benzoylformate 6.2 ± 0.21 6.5 ± 0.4 0.95 
Methyl o-chlorobenzoylformate 9.2 ± 0.9 2.8 ± 0.2 3.3 
Ethyl benzoylformate  2.35 ± 0.07 5.3 ± 0.4 0.44 
Isatin 22.0 ± 2.5 0.71 ± 0.11 31 
NADH  28.0 ± 2.5 0.16 ± 0.02 175 
[a]
 The activity was measured at 65°C as described in Materials and Methods. Kinetic 
constants for NAD+ and NADH were determined with 25 mM cycloheptanol and 
5 mM isatin, respectively. The kcat and Km data are the means ± standard deviations. 
 
enhances the reaction rate to 150%, due to the electronwithdrawing 
character of halogen; it also increases the affinity of the substrate, 
reflecting the hydrophobic character of the environment surrounding the 
phenyl group. Moreover, the specificity constant value is 21-fold higher for 
NADH than NAD+. These results suggest that the physiological direction 
of the catalytic reaction is reduction rather than oxidation. However, the 
natural substrate and function of SaADH are unknown. As far as the 
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substrate stereospecificity of SaADH is concerned the enzyme does not 
seem discriminate between the enantiomer S and R of 1-indanol, α-tetralol 
and 1-(2-naphthyl)ethanol, based on the similarity in the Km values. 
 
Coenzyme stereospecificity 
The 1H NMR spectrum of the deuterium-labelled NADD obtained by the 
reaction of SaADH with 1-phenylethanol-d9 and NAD+ shows a single peak 
at 2.68 ppm corresponding to the pro-R hydrogen at the C-4 position of 
NADD in place of a double doublet centered at 2.62 ppm present in the 
NADH spectrum (data not shown). The presence of a pro-S deuterium 
atom at C-4 of the pyridine ring of the NADD produced indicates that 
SaADH transfers the deuteride to the Si-face of NAD+, as illustrated in 
Fig. 13.  
 
Figure 13. Stereospecificity of hydrogen transfer catalysed by SaADH. R adenosine 
diphosphate ribose 
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Therefore, SaADH is a B-type (pro-S specific) dehydrogenase in 
agreement with the classification proposed by Schneider-Bernlöhr et al. 
(1986) that the SDRs enzymes are pro-S, whereas the medium-chain ADHs 
are pro-R, recently substantiated by the structural studies of Kwiecien et al. 
(2009). SaADH shares the same coenzyme stereospecificity with few other 
short-chain ADHs such as the thermophilic T. thermophilus ADH and the 
mesophilic enzymes Leifsonia sp. strain S749 ADH, 1-phenylethanol 
dehydrogenase from the denitrifying bacterium strain EbN1, and Mucor 
javanicus and Drosophila ADH (Pennacchio et al. 2010b and references 
therein). 
 
Thermal stability 
The thermal stability of SaADH was determined by measuring the residual 
enzymatic activity after 30 min of incubation over a temperature range 
from 25 to 95°C (Fig. 14). SaADH was shown to be quite stable up to a 
temperature of 80°C, above which its activity decreased abruptly, resulting 
in a T1/2 value (the temperature of 50% inactivation) of ~88°C. The residual 
activity measured after 24 h incubation in 50 mM Tris–HCl, pH 9.0, at 50 
and 70°C was 109 and 76%, respectively. In 50 mM Tris–H3PO4, pH 7.0, 
i.e., the buffer used for the bioconversion studies, the residual activity 
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measured after 6 and 24 h incubation at 50°C was 105 and 107%, 
respectively. 
 
 
Figure 14. Thermal denaturation of SaADH monitored by dehydrogenase activity. The 
stability was studied by incubating 0.2 mg mL-1 protein samples in 50 mM Tris–HCl, 
pH 9.0 for 30 min at the indicated temperatures. Activity measurements were carried 
out under the conditions of the standard assay using cycloheptanol as the substrate. The 
assay temperature was 65°C. 
 
Effects of various compounds 
The effects of salts, ions and reagents on SaADH activity were studied by 
adding each compound to the standard assay mixture (Table 9). The 
chlorides of Li+, Na+, K+, Ca2+, Mg2+, and Mn2+ did not affect the enzyme’s 
activity, whereas the sulphate of heavy metal ions such as Fe2+, Co2+, and 
Cu2+ caused a slight inactivation. Iodoacetate and Hg2+ did, to some extent, 
affect the activity, indicating that the only Cys residue per monomer, C67,  
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Table 9.   Effect of various compounds on SaADH [a] 
Compound Concn 
(mM) 
Relative 
activity 
(%) 
 
None 
 
 
 
100 
LiCl 1 110 
NaCl 1 
10 
88 
95 
KCl 1 
10 
99 
97 
MgCl2 1 
10 
94 
98 
CaCl2 1 
10 
100 
99 
MnCl2 1 95 
FeSO4  1 80 
CoSO4 1 89 
NiSO4 1 106 
CuSO4 1 89 
ZnSO4 1 91 
Hg(CH3COO)2 1 63 
2-Mercaptoethanol 5 112 
Iodoacetate 4 88 
o-Phenanthroline 1 110 
EDTA 1 
10 
93 
107 
[a] Each compounds was added to the reaction mixture 
   at the indicated concentration. The enzyme activity 
          was measured at 65°C using cycloheptanol as substrate. 
 
may have a functional role. The presence of metal-chelating agents did not 
affect enzyme activity, suggesting that either the protein does not require 
metals for its activity or the chelating molecule was not able to remove the 
metal under the assay conditions. Furthermore, the enzyme showed no loss 
in activity following exhaustive dialysis against EDTA. The EDTA 
dialysed enzyme turned out to be quite stable at 70°C for 6 h, both in the 
absence and the presence of EDTA or o-phenanthroline (data not shown). 
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These results suggest that SaADH does not require metals for its activity or 
structural stabilization. This is usual for the typically non-metal SDRs 
enzymes, although the well-known LB-RADH shows strong Mg2+ 
dependency (Niefind et al. 2003). 
 
Stability in organic solvents 
The effects of common organic solvents, such as 2-propanol, ethyl acetate, 
acetonitrile, n-hexane, n-heptane, tert-butylmethyl ether (TBME), 
methanol, and 1,4-dioxane, on SaADH were investigated at 50°C and at 
two different time points (Fig. 15 ). SaADH was activated up to 115% after 
incubation for 6 h in aqueous buffer and up to 120–125% after incubation 
for 25 h in the presence of 17% 2-propanol or 17% acetonitrile. Significant 
increases in enzyme activity occurred after 25 h incubation when ethyl 
acetate, n-hexane, n-heptane, TBME, and 1,4-dioxane were present at 30% 
concentration. Activity values ranged from 170 to 210% of the values 
determined prior to incubation. However, the presence of 2-propanol, 
acetonitrile, and 1,4-dioxane at a high concentration (30%) resulted in 
enzyme inactivation to 5–30% of the initial values following 5 h incubation 
at 50°C. Standard assays performed in the presence of 0.1–0.5% 2-propanol 
and 0.15% TBME did not affect enzyme activity, suggesting that the 
enhancement in activity was not due to an immediate effect of solvent on 
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Figure 15. Effect of organic solvents on SaADH. Samples of enzyme (0.5 mg mL-1) 
were incubated at 50°C in the absence and presence of the organic solvents at the 
concentrations indicated, and assays were performed after 6 h (white bars) and 25 h 
(grey bars). The activity assays were performed as described in Materials and Methods 
using (R)-α-tetralol as the substrate. The data obtained in the absence and presence of 
organic solvents are expressed as percentage of activity relative to the value determined 
prior to incubation. 
 
the protein structure. A considerable body of literature exists which 
describes the activation of thermophilic enzymes by loosening of their rigid 
structure in the presence of protein perturbants (Fontana et al. 1998; Liang 
et al. 2004). To account for the observed enhancements of SaADH activity, 
the organic solvent is proposed to induce a conformational change in the 
protein molecule to a more relaxed and flexible conformation that is 
optimal for activity. Analogously, the activating effect following heating of 
SaADH in aqueous buffer at 50°C over a short period (Fig. 15) may be due 
  
 66
to partial loosening of the overall structure, inducing an increased 
flexibility at the active site, and consequently an increased turnover. 
 
Enantioselectivity 
The enantioselectivity of SaADH was tested using α-methyl and α-ethyl 
benzoylformate, methyl o-chlorobenzoylformate, and 1-indanone as 
substrates, and an NADH regeneration system consisting of glucose and 
glucose dehydrogenase from Thermoplasma acidophilum (TaGDH), a 
thermophilic enzyme with dual coenzyme specificity, but with a marked 
preference for NADP(H) over NAD(H) (John et al. 1994). Tris–phosphate 
buffer pH 7.0 and 50°C was chosen as the pH and temperature conditions 
suitable for catalysis by the two archaeal enzymes. Thermal stability 
studies indicated that TaGDH activity dropped to ~70 and 35% following 
24 h incubation at 50°C in Tris–phosphate buffer, pH 7.0, in the absence 
and presence of 10% acetonitrile, respectively (data not shown). 
Bioconversions of EBF were carried out allowing the reactions to proceed 
for 1, 3, 6 and 24 h at 50°C. Fig. 16 shows that conversion of EFB was 
completed in 6 h. However, reaction times as long as 24 h did not improve 
the enantiomeric excess (ee) of the biotransformation. SaADH preferably 
reduced this keto ester to ethyl (R)-mandelate with an ee of 50%, after 6 h 
of reaction. 
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Figure 16. Reduction of ethyl benzoylformate catalysed by SaADH. Biotransformations 
were carried out at 50°C at different reaction times as described in Materials and 
Methods. The reactions were stopped by addition of ethyl acetate at the times indicated. 
The dried extracts were analysed by chiral HPLC to determine the relative conversion 
(RC, open bars) and the enantiomeric excess (ee, grey bars). 
 
Methyl benzoylformate was reduced by SaADH to methyl (S)-mandelate 
with 100% conversion after 6 h of reaction and an ee of 17%, and methyl 
o-chlorobenzoylformate was reduced to methyl (R)-o-chloromandelate with 
99% conversion and an ee of 72% (Table 10). These results show that 
enantioselectivity of SaADH is dependent upon the structure of both the 
phenyl group and alkyl substituent of the ester group of the substrate. 
1-indanone was reduced to the corresponding (S)-alcohol following a 6-h 
reaction at 50°C, with a conversion of 6% and an ee of 25%, reflecting the 
apparent inactivity under different assay conditions (see Table 7). It is 
noteworthy that the optically active alcohols produced are used as chiral 
building blocks in organic synthesis. Methyl (R)-o-chloromandelate is an  
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[a]
 Reactions were performed at 50°C for 6 h in the presence of 10% acetonitrile as 
described in Materials and Methods. Values in parentheses were obtained with 
bioconversions performed in the absence of acetonitrile. Conversion yields and 
enantiomeric excesses were determined by chiral HPLC analysis. Configuration of 
product alcohol was determined by comparing the retention time with that of standard 
samples as described in Material and Methods. 
 
intermediate for the platelet aggregation inhibitor clopidogrel (Ema et al. 
2008), and (R)-ethyl mandelate is precursor for the synthesis of 
cryptophycins (Gardinier and Leahy 1997). 
 
 
 
 
 
 
 
 
 
 
Table 10. Asymmetric reduction of carbonyl compounds by SaADH  
 
Substrate Product Conversion 
(%) [a] 
    ee 
(%) [a] 
R/S 
 
Methyl benzoylformate 
 
Methyl mandelate 
 
100 (100) 
 
 
36 (17) 
 
S 
Ethyl benzoylformate Ethyl mandelate 100 (100) 
 
34 (50) R 
Methyl o-
chlorobenzoylformate 
Methyl o-
chloromandelate 
100 (99) 72 (71) R 
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Conclusion 
Although the efficiency of conversion was more than satisfactory, the low 
purity of the preferred enantiomer precludes SaADH from use in utility-
scale applications. However, the work represents the first biochemical 
characterization of an NAD(H)-dependent archaeal short-chain ADH, and 
moreover. Moreover, the study adds further support for the critical role of 
the above-mentioned D37 in SDRs in discriminating NAD(H) from 
NADP(H) (Pennacchio et al. 2010a). 
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Biochemical and structural characterization of recombinant 
short-chain NAD(H)-dependent dehydrogenase/reductase 
from Sulfolobus acidocaldarius highly enantioselective on 
diaryl diketone benzil 
 
 
The second gene, saadh2, encoding a putative NAD(H)-dependent 
oxidoreductase has been heterologously overexpressed in Escherichia coli, 
and the resulting protein (SaADH2) purified to homogeneity and 
characterized in terms of substrate specificity, kinetics and stability. 
SaADH2 was found to be highly efficient and enantioselective in reducing 
the diaryl diketone benzil to (R)-benzoin, an useful building block. Detailed 
studies on 3D structure, performed in collaboration with Dr. L Esposito, 
have provided detailed insights into the enzyme enantioselectivity. 
 
Identification of the putative SDR oxidoreductase gene 
Analysis of the S. acidocaldarius genome (Chen et al. 2005) for genes 
encoding short-chain ADHs resulted in identification of a putative 
oxidoreductase gene. The sequence of the 27,024-Da protein, named 
SaADH2, showed the highest level of identity to four typical SDRs, LB-
RADH (29% identity), LsADH (34 %), TtADH (35%) and SaADH (30%; 
Fig. 17).  
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Figure 17. Multiple-sequence alignment of the S. acidocaldarius ADH (SaADH2) and 
ADHs belonging to the SDR family, including S. acidocaldarius ADH (SaADH; NCBI 
accession no. YP_256716.1), L. brevis ADH (LB-RADH; PDB code 1ZK4), Leifsonia 
sp. strain S749 ADH (LsADH; NCBI accession no. BAD99642) and T. thermophilus 
ADH (TtADH; PDB code 2D1Y). The sequences were aligned using the ClustalW2 
program. Grey shading indicates residues highly conserved in the SDR family. The four 
members of the catalytic tetrad are indicated by a black background. The following 
positions are indicated by bold type: the glycine-rich consensus sequence and the 
sequence motif Dhx[cp] that (in all SDRs) have a structural role in coenzyme binding 
(Kallberg et al. 2002). The star indicates the major determinant of the coenzyme 
specificity. The LB-RADH G37D mutant shows preference for NAD+ over NADP+ 
(Schlieben et al. 2005) 
 
Expression and protein purification 
The saadh2 gene successfully expressed in E. coli cells, yielded an active 
enzyme accounting for about 9% of the total protein content of the cell 
extract (Table 11).  
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Table 11.  Purification of recombinant Sulfolobus acidocaldarius ADH [a] 
 
Step Total 
protein 
(mg) 
Total 
activity 
(U) 
Specific 
activity 
(U/mg) 
Yield 
(%) 
Purification 
(fold) 
Crude extract 500 3,554 7.1 100 1 
Thermal step 174 2,843 16.3 80 2.3 
DEAE FF 63 2,170 34.4 61 4.8 
Gel filtration 44 1,704 38.7 48 5.4 
[a] The data are for a 2-liter culture. The substrate was cycloheptanol, 
                     and the assay temperature was 65°C. 
 
Host protein precipitation at 70°C was found to be the most effective 
purification step. An overall purification of 5.4-fold was achieved from 
crude-cell-free extracts with an overall yield of 48%. SDS-PAGE of the 
purified protein showed a single band corresponding to a molecular mass of 
29 kDa (data not shown).  
 
The quaternary structure of SaADH2 
The quaternary structure of the enzyme was investigated by sucrose density 
gradient centrifugation. SaADH2 sedimented as one peak nearly 
overlapping that of TtADH (Fig. 18). The plot of molecular mass of the 
markers vs fraction number (inset Fig. 18) allowed to determine an 
apparent molecular mass of 109±10 kDa for SaADH2. The molecular mass 
of the subunit determined by ESI-MS analysis proved to be 27,024.0 Da 
(average mass), in agreement with the theoretical value of the sequence. 
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Figure 18. Sucrose gradient centrifugation analysis of SaADH2. 5–25% sucrose 
gradient was used as described in Material and Methods. Positions of the standards and 
that of SaADH2 are shown: (1) Chymotrypsinogen; (2) BSA; (3) T. thermophilus ADH; 
(4) S. solfataricus ADH; (5) SaADH2. Absorbance values were corrected for the blank 
i.e. from a blank gradient. The inset shows the semiplot of the molecular masse of the 
standards 1 to 4 vs fraction numbers. The star indicates the position of SaADH2. 
 
Optimal pH 
The pH dependence of SaADH2 in the reduction and oxidation reaction 
was analysed (Fig. 19). The SaADH2 activity was found to be closely 
dependent on pH in the reduction reaction, displaying a peak of maximum 
activity at around pH 5.0. The oxidation reaction showed a less marked 
dependence on pH, displaying a peak with a maximum at around pH 10.0. 
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Figure 19. SaADH2 activity as a function of pH in the reduction and oxidation 
reactions. The following buffer solutions at concentrations ranging from 25 to 55 mM 
were used: sodium citrate (○), sodium phosphate (∆), and Tris-HCl (□) in the reduction 
reaction, and sodium phosphate (●), glycine-NaOH (▲), sodium citrate (■), and sodium 
phosphate (♦) in the oxidation reaction. The mixture for the reduction reaction contained 
20 mM EMO and 0.2 mM NADH, and the mixture for the oxidation reaction contained 
18 mM cycloheptanol and 3 mM NAD+. The assays were performed at 65°C under the 
conditions described in Materials and Methods. 
 
Thermophilicity and thermal stability 
The effect of temperature on SaADH2 activity is shown in Fig. 20. The 
reaction rate increases up to 78°C and then decreases rapidly due to thermal 
inactivation. This optimal temperature value is similar to that of TtADH 
(73°C) and SaADH (75°C) (Pennacchio et al. 2008; 2010a, b), and lower 
than that of P. furiosus aldo-keto reductase (100°C) (Machielsen et al. 
2006). The thermal stability of SaADH2 was determined by measuring the 
residual enzymatic activity after 30 min of incubation over a temperature 
range from 25 to 95°C (Fig. 20). SaADH2 was shown to be quite stable up 
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to a temperature of ~75°C, above which its activity decreased abruptly, 
resulting in a T1/2 value (the temperature of 50% inactivation) of ~88°C.  
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Figure 20. Effect of temperature on activity and stability of SaADH2 monitored by 
dehydrogenase activity. The assays at the increasing temperature values (triangles) were 
carried out as described in Materials and Methods, using cycloheptanol as the substrate. 
The thermal stability (circles) was studied by incubating 0.2 mg mL−1 protein samples 
in 50 mM Tris–HCl, pH 9.0 for 30 min at the indicated temperatures. Activity 
measurements were carried out under the conditions of the standard assay using 
cycloheptanol as the substrate. The assay temperature was 65°C. The percentage of 
residual activity was obtained by the ratio to the activity without heating. 
 
Coenzyme and substrate specificity 
The enzyme showed no activity with NADP(H) and full activity with 
NAD(H). The specificity of SaADH2 for various alcohols, aldehydes and 
ketones was examined (Table 12). SaADH2 is more similar to the archaeal 
thermophilic TtADH and SaADH (Pennacchio et al. 2008; 2010a, b), than 
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to the two representative SDR mesophilic ADHs, i.e. LB-RADH 
(Schlieben et al. 2005) and LsADH (Inoue et al. 2006), which are active on 
a variety of aliphatic as well as aromatic alcohols, ketones, diketones and 
keto esters.  
The enzyme showed a poor activity on a discrete number of aliphatic linear 
and branched alcohols, such as 2-propyn-1-ol, 4-methyl-1- pentanol, the S 
enantiomers of 2-butanol and 2-pentanol as well as on aliphatic cyclic and 
bicyclic alcohols, except for isoborneol and cycloheptanol which rank first 
and second, respectively, among the tested alcohols. Benzyl alcohol and 
substituted benzyl alcohols were found to be poor substrates. Among the 
aromatic secondary alcohols tested SaADH2 showed a low activity on (S)-
1-phenylethanol and no activity with the R enantiomer, whereas displayed 
similar poor activities towards the (S)- and (R)- forms of α-
(trifluoromethyl)-benzyl alcohol, 1-(2-naphthyl)ethanol and methyl and 
ethyl mandelates. Moreover, the enzyme showed poor activity on (±)-1-
phenyl-1-propanol and its ortho-chloro derivative, and para-halogenated 1-
phenylethanols. However, SaADH2 showed a relatively high activity with 
1-indanol and α-tetralol, but a poor activity on the β-hydroxy ester ethyl 
(R)-4-chloro-3-hydroxybutyrate. The enzyme was not active on aliphatic 
and aromatic aldehydes, and on aliphatic linear, and branched ketones (data 
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not shown). However, it was active on aliphatic cyclic and bicyclic ketones 
such as cyclohexanone, methyl-substituted cyclohexanones and decalone  
[a]
 The activity was measured at 65°C as described in Materials and Methods.  
    The concentration of each substrate was 5 mM. 
[b]
 The substrates were dissolved in 100% 2-propanol. 
[c]
 The percent values refer to cycloheptanol for alcohols, benzyl for ketones and to  
     ethyl 3-methyl-2-oxobutyrate for keto esters.  
[d]The substrate was dissolved in 100% acetonitrile. 
 
Table 12. Substrate specificity of SaADH2 in the oxidation and reduction reactions[a] 
 
Substrate                                             Relative activity    Substrate                                     Relative activity 
                                                                 (%) [c]                                                                         (%) [c] 
Alcohols    
2-Propyn-1-ol 5 1-(2-Chlorophenyl)-1-propanol[b] 2 
4-Methyl-1-pentanol 2 (±)-1-Indanol[d] 26 
(S)-2-Butanol 3 (±)-α-Tetralol[b] 51 
(R)-2-Butanol 0 (±)-1-(2-Naphthyl)ethanol 2 
2,3-Butanediol 2 (S)-1-(2-Naphthyl)ethanol 3 
(±)-2-Pentanol 2 (R)-1-(2-Naphthyl)ethanol 2 
(S)-2-Pentanol 7 Benzoin 0 
(R)-2-Pentanol 0 trans-1,3-Diphenyl-2-propen-1-ol 5 
3-Pentanol 1 Ethyl (R)-4-chloro-3-hydroxybutyrate 2 
2-Hexanol[b] 2 Methyl (S)-(−)-mandelate 4 
2-Heptanol[b] 2 Methyl (R)-(+)-mandelate 3 
6-Methyl-5-hepten-2-ol[b] 3 Ethyl (S)-(−)-mandelate 2 
1-Octanol 1 Ethyl (R)-(+)-mandelate 2 
Geraniol 2 Ketones[b]  
Cyclopentanol 2 Cyclohexanone 13 
Cyclohexanol 6 2-Methylcyclohexanone 33 
3-Methylcyclohexanol[b] 10 3-Methylcyclohexanone 60 
Cycloheptanol 55 4-Methylcyclohexanone 41 
Cyclohexylmethanol[b] 2 Cycloheptanone 0 
2-Cyclohexylethanol 1 1-Decalone 85 
Chrysanthemyl alcohol 1 (±)-Camphor 0 
cis-Decahydro-1-naphthol 3 Acetophenone 0 
Isoborneol 100 2,2-Dichloroacetophenone 30 
Benzyl alcohol 7 2,2,2-Trifluoroacetophenone 35 
2-Methoxybenzyl alcohol 5 2',3',4',5',6'-Pentafluoroacetophenone 45 
3-Methoxybenzyl alcohol 6 1-Phenyl-1,2-propanedione 100 
4-Methoxybenzyl alcohol 3 1-Indanone[d] 0 
4-Bromobenzyl alcohol[b]  9 α-Tetralone 0 
(R,S)-1-Phenylethanol[b] 2 Benzil 62 
(S)-(−)-1-Phenylethanol 6 2,2’-Dichlorobenzil 0 
(R)-(+)-1-Phenylethanol 0 Chalcone 0 
(R,S)-α-(Trifluoromethyl)benzyl alcohol 2 Keto esters[b]  
(S)-α-(Trifluoromethyl)benzyl alcohol 2 Ethyl pyruvate 16 
(R)-α-(Trifluoromethyl)benzyl alcohol 2 Ethyl 3-methyl-2-oxobutyrate 100 
1-(4-Fluorophenyl)ethanol[b] 5 Ethyl 4-chloroacetoacetate 0 
1-(4-Chlorophenyl)ethanol[b] 2 Methyl benzoylformate  8 
(±)-1-Phenyl-1-propanol[b] 2 Methyl o-chlorobenzoylformate 5 
trans-Cinnamyl alcohol[b] 2 Ethyl benzoylformate 23 
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(Table 12). Two aryl diketones, 1-phenyl-1,2-propanedione and benzyl 
were good substrates of SaADH2 which also showed a relatively high 
reduction rate with 2,2-dichloro- and 2,2,2-trifluoroacetophenone and 
penta-substituted fluoroacetophenone (Table 12). 
The electronic factor accounts for the relatively high activity measured 
with the halogenated acetophenones, as compared to the apparent zero 
activity observed with acetophenone. The electron withdrawing character 
of fluorine (or chlorine) favours hydride transfer, inductively decreasing 
electron density at the acceptor carbon C1. On the other hand, the 
corresponding ketones of cycloheptanol and isoborneol, cycloheptanone 
and camphor did not show any apparent activity due to the deactivating 
effect exerted by the electron donating alkyl groups on the acceptor carbon 
C1. SaADH2 was also active on aliphatic and aryl α-keto esters but not on 
β-ketoesters (Table 12). 
 
Kinetic studies 
The kinetic parameters of SaADH2 determined for the most active 
substrates are shown in Table 13. Based on the specificity constant 
(kcat/Km), isoborneol is the best substrate in the oxidation reaction; 
compared to the alicyclic cycloheptanol and aromatic bicyclic alcohols, it 
displays a higher affinity to the active site probably due to its alicyclic 
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bridged structure. However, the enzyme shows a 6-fold greater preference 
for (S)- than (R)-1-indanol and a 23-fold greater preference for (S)- than  
Table 13. Steady-state kinetic constants of SaADH2 [a] 
 
Substrate 
kcat 
(s–1) 
Km 
(mM) 
kcat/Km 
(s–1 mM–1) 
Cyclohepthanol 7.0 5.1 1.37 
Isoborneol 16.6 0.81 20.5 
(±)-1-Indanol 6.2 8.7 0.71 
(R)-Indanol 2.7 15.3 0.18 
(S)-Indanol 10.6 10.0 1.06 
α-Tetralol 9.6 8.5 1.13 
(R)-α-Tetralol 1.15 9.2 0.13 
(S)-α-Tetralol 6.0 2.0 3.0 
NAD+  19.3 0.18 107 
Benzil 1.6 0.43 3.72 
1-Phenyl-1,2-propanedione 5.3 5.0 1.06 
2,2-Dichloroacetophenone 0.65 0.11 5.91 
2,2,2-Trifluoroacetophenone 1.7 6.3 0.27 
2’,3’,4’,5’,6’-Pentafluoroacetophenone 3.2 11.9 0.27 
Ethyl 3-methyl-2-oxobutyrate 26 16.6 1.57 
Ethyl benzoylformate  1.9 4.2 0.45 
NADH 26.2 0.04 655 
[a]
 The activity was measured at 65°C as described in Materials and 
          Methods. Kinetic constants for NAD+ and NADH were determined 
       with 15 mM isoborneol and 30 mM ethyl 3-methyl-2-oxobutyrate, 
                        respectively. 
 
(R)-α-tetralol. In the reduction reaction, 2,2-dichloroacetophenone was 
preferred 22-fold more than 2,2,2-trifluoroacetophenone and 2′,3′,4′,5′,6′-
pentafluoroacetophenone, and 1.6- and 6-fold more than the two diketones, 
benzil and 1-phenyl-1,2-propanedione, respectively, due to its higher 
affinity. Ethyl 3-methyl-2-oxobutyrate shows the highest turnover among 
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the carbonyl compound tested, although it binds to the catalytic site with 
relatively low affinity. Moreover, the specificity constant value is 6-fold 
higher for NADH than NAD+.  The kinetic data show that for most of 
chiral substrates SaADH2 is (S)-stereospecific and that the physiological 
direction of the catalytic reaction is reduction rather than oxidation (Table 
13).  
 
Effects of various compounds 
The effects of salts, ions and reagents on SaADH2 activity were studied by 
adding each compound to the standard assay mixture. The enzyme activity 
in the presence of 1 mM of the Li+, Na+, K+, Ca2+, Mg2+ and Mn2+ chlorides 
was 115, 113, 102,101, 101 and 110%, respectively, and in the presence of 
1 mM of the sulphate of heavy metal ions such as Fe2+, Co2+, Ni2+,Cu2+ and 
Zn2+ was 93, 108, 104, 102 and 107%, correspondingly, when compared to 
the enzyme activity measured in the absence of additional metal ions. The 
presence of 5% ionic liquid (BMIMBF4) inactivated by 50% the enzyme 
presumably due to a competition of the BF4− ion with the coenzyme 
phosphate moiety for the anion-binding site of the enzyme. The addition of 
4 mM iodoacetate and 1 mM Hg2+ had no significant influence on the 
enzyme activity, which resulted in 101 and 113% of the control activity, 
respectively, suggesting that the only Cys residue per monomer, C90, has 
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no functional role. Even the metal-chelating agents did not affect enzyme 
activity. The enzyme activity in the presence of either 1mM o-
phenanthroline, or 10 mM EDTA was 98 and 87%, respectively, suggesting 
that either the protein does not require metals for its activity or the 
chelating molecule was not able to remove the metal under the assay 
conditions. Furthermore, the enzyme showed no loss in activity following 
exhaustive dialysis against EDTA. The EDTA-dialysed enzyme turned out 
to be quite stable at 70°C for 5 h, both in the absence and the presence of 
EDTA (data not shown). The analysis of the effects of ions reveals that 
SaADH2 does not require metals for its activity or structural stabilization; 
this is typical of non-metal SDR enzymes, although the well-known LB-
RADH shows strong Mg2+ dependency (Niefind et al. 2003). 
 
Stability in organic solvents 
The effects of common organic solvents, such as acetonitrile, DMSO, 1,4-
dioxane and ethyl acetate on SaADH2 were investigated at 50°C, at two 
different time points and 18% concentration (Fig. 21). SaADH2 activated 
after 6 and 24 h incubation in aqueous buffer (120 and 105% the initial 
values, respectively), and inactivated by 15 and 30% in the presence of 
18% acetonitrile following incubation for 6 and 24 h, respectively. A 
slightly reduced activity (95%) remained after 6 and 24 h incubation in 
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aqueous solution containing 18% ethyl acetate. Interestingly, significant 
increases in enzyme activity occurred after 6 h incubation in the presence  
Solvent   (18%)
N
o
n
e
D
M
SO
 
A
c
e
to
n
itr
ile
 
1,
4-
D
io
x
a
n
e
 
Et
hy
l a
c
e
ta
te
 
Ac
tiv
ity
 
 
 
(%
) 
0
20
40
60
80
100
120
140
 
Figure 21. Effects of various solvents on SaADH2. Samples of enzyme (0.20 mg mL–1) 
were incubated at 50°C in the absence and presence of the organic solvents at 18% 
concentrations, and the assays were performed after 6 h (white bars) and 24 h (grey 
bars). The activity assays were performed at 50°C as described in Materials and 
Methods using cycloheptanol as the substrate. The data obtained in the absence and 
presence of organic solvents are expressed as percentage of activity relative to the value 
determined prior to incubation. 
 
of 18% DMSO (>140%) and 1,4-dioxane (135%). After 24 h incubation in 
the presence of these two solvents, the enzyme activity remained nearly 
unchanged with respect to the initial value. The activation of thermophilic 
enzymes by loosening of their rigid structure in the presence of protein 
perturbants is a well documented phenomenon (Fontana et al. 1998; Liang 
et al. 2004). The two organic solvents discussed above (Fig. 21) may 
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induce a conformational change in the protein molecule to a more relaxed 
and flexible state that is optimal for activity. 
 
Enantioselectivity 
The enantioselectivity of SaADH2 was tested on benzil using an NADH 
recycling system consisting of thermophilic NAD(H)-dependent BsADH 
(Fig. 22).  
 
Figure 22. Coenzyme recycling in the production of chiral diaryl alcohol with SaADH2 
utilizing BsADH and 1-butanol. 
 
As previously mentioned, BsADH is mainly active on aliphatic and 
aromatic primary and secondary alcohols and aldehydes, but not on 
aliphatic and aromatic ketones, nor on the carbonyl substrates of SaADH2 
and corresponding alcohols (data not shown). Since 2-propanol is not a 
substrate of SaADH2, it may be a suitable substrate for BsADH in NADH 
recycling, as well as being used as a co-solvent. Bioconversions were 
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carried out for 24 h using 5 mM benzil as substrate and 2-propanol at three 
different concentrations. Sodium phosphate buffer, pH 7.0 and 50°C was 
chosen as a compromise between cofactor stability and catalytic activity of 
the two ADHs at suboptimal pH (Pennacchio et al. 2008.). Chiral HPLC 
analysis of the extracts obtained from the bioconversions showed that 
benzyl was reduced by the archaeal enzyme to the (R)-enantiomer of 
benzoin with a level of conversion of 35, 100 and 99% and an enantiomeric 
excess (ee) of 85, 82 and 80% using 4, 14 and 18% (v/v) 2-propanol as 
ancillary substrate, respectively. 
In addition to 2-propanol (kcat/Km = 9 s−1 mM−1), BsADH oxidizes other 
alcohols with even greater efficiency such as ethanol (kcat/Km = 64 s−1 
mM−1), 1-propanol (286 s−1 mM−1), 1-butanol (437 s−1 mM−1), 1-pentanol 
(64 s−1 mM−1) and 1-hexanol (64 s−1 mM−1; Raia, unpublished data).We 
therefore tested these alcohols as alternative hydride source for NADH 
recycling and also to improve the solubility of the substrate in the aqueous 
phase. Moreover, these alcohols and the respective aldehydes are not 
substrates of SaADH2. Thus, only the cofactor is the co-substrate of 
SaADH2 and BsADH.  
Fig. 23 summarizes the results of the bioconversions carried out using 
different alcohol substrates at 18% concentrations. As for the case of 2-
propanol, benzil was reduced to the (R)-alcohol with excellent conversion 
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(>99%) but modest enantioselectivity using ethanol and 1-propanol. 
However, in the presence of 1-butanol, 1-pentanol and 1-hexanol excellent 
optical purity (98–99% ee) and levels of conversion decreasing from 98 to  
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Figure 23. Reduction of benzil catalyzed by SaADH2. Biotransformations were carried 
out at 50°C with different alcohols at 18% (v/v) concentrations. The reactions were 
stopped after 24 h by addition of ethyl acetate. The dried extracts were analysed by 
chiral HPLC to determine the relative conversion (RC, grey bars) and the enantiomeric 
excess (ee, dark grey bars). Error limit, 2% of the stated values. The alcohols are 
plotted according to increasing log P (P=partition coefficient) values; from left to right: 
log P =−0.24, 0.07, 0.28, 0.8, 1.3 and 1.8. Log P values were from Laane et al. (1987). 
 
93% and 66%, respectively, were obtained. This suggests that ethanol and 
linear/branched propanol acted as good substrates and solvents for the 
bioconversion system, but negatively affected the prochiral selectivity of 
SaADH2 that was instead enhanced by longer chain-linear alcohols (four to 
six carbons). The decrease in conversion rate with 1-pentanol and 1-
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hexanol could be due to different effects: (1) substrate excess inhibition, (2) 
BsADH deactivation and (3) reduced substrate solubility. The finely tuned 
solvent dependence of the prochiral selectivity shown by SaADH2 is 
remarkable and agrees with the general observation that enzyme selectivity 
(enantiomeric, prochiral and regiomeric) can change, or even reverse, from 
one solvent to another (Carrea and Riva 20050; Klibanov 2001). Overall, 
the solvent enantioselectivity study emphasizes the versatility and high 
efficiency of the BsADH/ alcohol substrate system in recycling the reduced 
cofactor. α-Hydroxy ketones are highly valuable building blocks for many 
applications for the fine chemistry sector as well as pharmaceuticals 
(Hoyos et al. 2010). It is noteworthy that optically pure (R)-benzoin is 
useful as urease inhibitor (Tanaka et al. 2004), and to prepare amino 
alcohols used as important chiral synthons (Aoyagi et al. 2000), or to 
synthesize different heterocycles (Wildemann et al. 2003). Many examples 
of stereoselective reduction of several benzyls to the corresponding 
benzoins using whole microbial cells have been recently reviewed (Hoyos 
et al. 2010). The microorganisms Bacillus cereus, Pichia glucozyma, 
Aspergillus oryzae, Fusarium roseum, Rhizopus oryzae (at pH 4.5–5.0) and 
B. cereus Tm-r01 were reported to give (S)-benzoin while the 
microorganisms R. oryzae (at pH 6.8–8.5) and Xanthomonas oryzae were 
reported to transform benzil to (R)-benzoin with different yields and optical 
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purity (Hoyos et al. 2010 and references therein). However, recombinant B. 
cereus NADPH-dependent benzil reductase belonging to SDR superfamily 
which reduces benzil to 97% optically pure (S)-benzoin in vitro was 
characterized (Maruyama et al. 2002).  
The SaADH2 enantioselectivity was further examined with other aromatic 
ketones using the system BsADH/1-butanol.  
Table 14 shows that SaADH2 preferably reduced benzil to (R)-benzoin 
with an ee of 98% and 98% conversion after 24 h of reaction, and that the 
selectivity was reduced when 2-propanol instead of 1-butanol was used. 
 
Table 14.  Asymmetric reduction of carbonyl compounds by SaADH2 [a] 
 
Substrate Product Conversion 
(%) 
ee 
(%) 
R/S 
 
Benzil 
 
Benzoin 
 
98(99) 
 
 
98(80) 
 
 
R 
 
2,2’-
Dichlorobenzil 
1,2-Bis(2-chlorophenyl)-
2-hydroxyethanone 
 
33 
 
91 
 
R 
Acetophenone 1-Phenylethanol 4 92 S 
[a]
 Reactions were performed at 50°C for 24 h as described in Materials and 
Methods, using 18% 1-butanol as ancillary substrate. Conversion and enantiomeric 
excess were determined by chiral HPLC analysis. Configuration of product alcohol 
was determined by comparing the retention time with that of standard samples as 
described in Material and Methods. Values in parentheses refer to data obtained with 
18% 2-propanol as ancillary substrate. 
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However, 2,2′-dichlorobenzil was reduced to (R)-1,2-bis(2-chlorophenyl)-
2-hydroxyethanone with lower conversion (33%) and ee of 91%, despite 
the apparent inactivity under different assay conditions (Table 12). 
Presumably, the presence of chlorine, a bulky atom with electron-
withdrawing properties, disturbs the fitting of the diketone molecule in the 
substrate-binding pocket as well as the interactions that stabilize the 
transition state. Acetophenone was reduced to (S)-1-phenylethanol with a 
4% conversion and an ee of 92%, while no conversion was observed for 
camphor, the ketone corresponding to the highly preferred alcohol 
isoborneol (see Table 13). Kinetic tests showed that neither racemic 
benzoin nor (R)-benzoin was oxidized in the presence of NAD+ as well as 
both were not reduced in the presence of NADH. Accordingly, the HPLC 
analysis indicated that no further reduction of benzoin occurred since no 
trace of hydrobenzoin could be found within the detection limits (data not 
shown). 
 
Structural characterization 
The functional characterization of SaADH2 was complemented by the 
determination of the crystal structure of SaADH2–NADH complex at 1.75 
Å resolution. The determined crystal structure reveals a tetrameric 
organization similar to other members of the short chain 
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dehydrogenase/reductase (SDR) family that corroborates the results 
obtained by sucrose density gradient centrifugation. Although SaADH2 has 
low sequence similarities with other SDR proteins, it shares common 
structural features with them (Kallberg et al. 2002; Kavanagh et al 2008). 
The overall structure is typical of SDRs that is an α/β fold with 
characteristic Rossmann-fold motifs for the binding of the dinucleotide 
cofactor at the N-terminal region of the chain. Indeed, the structure 
confirmed that SaADH2 is a NAD-dependent enzyme with a cofactor-
binding domain composed of a seven-stranded parallel sheet flanked by 
helices on each side.  
 
Overall tertiary and quaternary structure  
The structural comparison of SaADH2 with other SDRs demonstrated that 
SaADH2 exhibits a high degree of overall structural homology despite the 
low sequence similarities. Indeed, when aligning the monomeric structures 
by the DALI server the first 100 best superimpositions showed RMS 
deviations on Cα atoms ranging from 1.5 to 2.5 Å (with a minimum of 
222/255 aligned residues). Some structural neighbours are superimposed 
onto a single chain of SaADH2 in Fig. 24. Major conformational 
differences are found on the molecular surface and at the C terminal region 
of the polypeptide chain which contributes to the shaping of the active site. 
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Analysis of the crystal packing (using PISA server: 
http://www.ebi.ac.uk/pdbe/prot_int/pistart.html), indicates that the tetramer 
is the biologically active form. 
 
Figure 24. Superimposed Cα traces of SaADH2 single chain (cyan) and some of its 
structural neighbours, as derived from the DALI server 
(http://ekhidna.biocenter.helsinki.fi/dali_server). The NADH molecule of SaADH2 
structure is highlighted in dark grey as ball-and-stick representation. The black ellipse 
includes the substrate binding loop region (SaADH2 residues 193-211).  
The structural alignment includes: SaADH2 (cyan); T. thermophilus ADH (PDB code 
2D1Y) (orange); 3-oxoacyl-(acyl carrier protein) reductase from B. anthracis (PDB 
code 2UVD) (blue); L. brevis ADH (PDB code 1ZK4) (red); C. acquaticum levodione 
reductase (PDB code 1IY8) (grey); P. falciparum Oxoacyl-acp reductase (PDB code 
2c07) (green); S. Clavuligerus clavulanic acid dehydrogenase (PDB code 2JAP) 
(yellow); putative glucose/ribitol dehydrogenase from C. thermocellum (PDB code 
2HQ1) (magenta). 
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The tetramer shows 222 point group symmetry and approximate 
dimensions of 80×70×55 Å (Fig. 25).  
 
 
Figure 25. Ribbon diagram of the overall structure of tetrameric SaADH2 in complex 
with NADH (magenta). The chains are shown in cyan (A), green (B), yellow (C), and 
red (D). 
 
 
The largest dimeric interface is the one involving AB or CD assemblies 
(∼1,630 Å2). The central elements in this interface are the long α6 helices 
(residues 156–179, Fig. 26) facing each other from adjacent subunits. Other 
segments involved in this interface are α4 and α5 helices (Fig. 26).  
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Figure 26. Sequence and secondary structure of SaADH2. The α-helices and β-strands 
are indicated with H and E, respectively, and numbered sequentially. Small 310 helical 
segments are indicated with G. 
 
The second large interface involving AC or BD assemblies (∼1,250 Å2) 
mainly comprises the Cterminal regions (residues 216–255) of the two 
subunits. The very terminal segment (residue 253–255) also contributes to 
the smallest interface involving AD or BC assemblies (∼445 Å2); indeed, 
this segment forms inter-subunit interactions with residues belonging to 
150–153 segment. It is worth noting that residues from the 209–218 region 
of the structure also mediate intersubunit interactions in this interface. 
 
Cofactor-binding site 
The reductase activity measurements showed that the protein is not active 
with NADP(H), having a definite preference for NAD(H) cofactor. This 
cofactor specificity is consistent with structural results.  
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A highly defined electron density was observed for the whole NAD(H) 
molecule thus allowing unambiguous identification of the positions of the 
cofactor in all the four molecules of the asymmetric unit (Fig. 27).  
 
Figure 27. Electron density for NAD(H) (magenta) and glycerol molecules (GOL, 
green) of chain C. The Fo-Fc omit map is contoured at 2.5σ. All the residues having at 
least one atom within 5.0 Å from NADH molecule are represented in stick. Some 
residue labels are omitted for clarity. 
 
The cofactor binding site is located at the C-terminal end of the central 
parallel β-sheet. The NAD(H) cofactor specificity is explained by the 
presence of Glu39 whose side chain oxygen atoms form hydrogen bonds 
with two oxygen atoms of the adenosine ribose of NAD(H) hampering the 
binding of NADP(H). The adenine ring of NAD binds in a hydrophobic 
pocket on the enzyme surface formed by the side chains of Val116, Leu40, 
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Val66, Ala93 and Gly15. Hydrogen bonds are formed by N6 of adenine 
and the Asp65 side chain and by N1 and the peptide nitrogen of Val66. 
The segment 14-TGAGSGIG-21 corresponds to the glycine-rich sequence 
(TGxxx[AG]xG) present in NAD-binding site of “classical” SDR 
(Kavanagh et al 2008). This region interacts with the adenine ribose and the 
diphosphate moiety of NAD(H). 
The phosphate groups also interact with Thr193-Ala194. The 2′- and 3′-
hydroxyls of the second ribose, attached to the nicotinamide ring, form a 
bifurcated hydrogen bond with Lys162. The 3′-hydroxyl is also hydrogen 
bonded to the active site Tyr158. The syn face of the nicotinamide ring 
displays vdW contacts with the hydrophobic side-chains of Ile20, Pro188 
and Val191. The amide part of the nicotinamide portion is anchored to the 
protein by hydrogen bonds to Thr193 and Val19.  
 
Substrate-binding site 
The SaADH2 contains the conserved catalytic residues, Ser145, Tyr158 
and Lys162, located in the active-site cleft with position and orientation 
similar to those found in other SDRs (Schlieben et al. 2005). Besides the 
catalytic triad, also Asn117 is structurally conserved; this residue has been 
suggested as a key residue in a catalytic mechanism based on a tetrad 
instead of a triad (Filling et al. 2002) and  it plays a role in maintaining the 
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active-site architecture and the building up of a proton-relay system in SDR 
structures (Filling et al. 2002; Schlieben et al. 2005). Moreover, its side 
chain atoms form hydrogen bonds with main chain atoms of Ile95. In many 
SDRs the substrate-binding site is a deep cleft with a floor created by the 
NADH molecule and the rightside and left-side walls formed by the 
substrate-binding region (residues 193-221 in SaADH2 numbering) and the 
loop between β5 and β6 strands (Fig. 28). 
 
 
Figure 28. Overall tertiary structure of one of the subunits of SaADH2. Bound NADH 
is shown in stick representation (magenta). The substrate-binding loop, the stretches 
152–155 and 96–101 are highlighted in blue, yellow and red, respectively. The arrows 
point toward the substrate-binding cleft; the directions of approach are shown in 
magenta and black (see the text for details). 
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In three out of four subunits of the asymmetric unit there is a glycerol 
molecule occupying the position that is approximately suited for the 
binding of substrate. Indeed, the glycerol O2 and O3 oxygen atoms are 
hydrogen bonded to the oxygen of the NAD carboxamide and to the 
oxygen of Tyr158 side chain, respectively. Glycerol was used as 
cryoprotectant agent and therefore diffused through the water channels of 
the crystals up to the binding site. The lacking of glycerol binding in one of 
the subunits (chain B) of the tetramer is due to crystal packing which 
restricts the access to NADH in subunit B. Indeed, a nearby symmetric 
molecule (#B) inserts its 50–57 region into the substrate-binding region 
(residues 193–221) that covers the access to the NADH site. On the other 
hand, the other subunits of the tetramer do not show direct interactions with 
adjacent symmetric molecules through the substrate-binding loop. It is 
worth noting that, despite the different crystal environments experienced by 
the four molecules of the asymmetric unit, the substrate-binding loops 
adopt similar conformations in the four subunits of the tetramer with 0.36–
0.68 Å. Furthermore, the structure of the loop (residues 193–221, in blue in 
Fig. 24) represents the most significant difference between SaADH2 and 
the other SDR structures aligned with it. Indeed, as can be seen in Fig. 24, 
this loop (in cyan) is remarkably different from the other structures. This is 
not unexpected since the conformation, the length and the composition of 
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the substrate-binding loop are rather variable in SDR proteins thus 
conferring different substrate specificity. In most of SDR structures the 
substrate binding loop contains two segments of α-helix on opposite sides 
of the loop. In addition, part of the loop is often disordered thus revealing a 
considerable mobility. In SaADH2 the loop shows the following features: 
(1) it is well defined in the electron density; (2) it contains only one stretch 
of α-helix lacking the one usually present at the Cterminal end and (3) it 
partially obstructs the access to the substrate-binding cleft indicated with a 
magenta arrow in Fig. 24. Indeed, a detailed comparison with other SDR 
aligned structures reveals that three stretches (193–221, 96–101 and 152–
155) of SaADH2 structure adopt a different conformation by getting closer 
to the NADH nicotinamide ring which becomes inaccessible to 
solvent/substrate from the top of the molecule (magenta arrow in Fig. 24). 
Interestingly, the segment 152.155 contains a Phe residue (Phe153) which 
points deep into the active site and can play a relevant role for substrate 
specificity (Fig. 28). The region 96–101 is also closer to the nicotinamide 
ring thus contributing to the reduced accessibility of the site where hydride 
transfer has to occur (Fig. 28).  The cofactor ring is, however, still 
accessible to ligands through a side cavity (black arrow in Fig. 24) lined by 
residues Met96, Ser145, Ile146, Ala147, Phe153, Ala154, Tyr158, Gly189, 
Thr190, Ile195, Gly196, Leu197, Leu210 and Met214 (Fig. 29). As a 
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consequence, the manual modelling of the bulky benzyl molecule in the 
active site, guided by the position of glycerol molecule bound and by 
preliminary results of rigid docking, cannot avoid the presence of 
unfavourable contacts. However, it can be suggested that minor changes in 
the three segments of the protein structure discussed above as well as in the 
conformation of the benzil α-diketone may well accommodate this 
substrate in the site (Fig. 30).  
 
Figure 29. Stick representation of residues from the substrate binding pocket (the 
subunit C of the tetramer is considered). The NAD(H) molecule is depicted in magenta, 
whereas the glycerol molecule is in green. 
 
The mouth of the cavity is composed of atoms from residues 190, 195–197, 
210 and 214, as confirmed by CastP server 
(http://sts.bioengr.uic.edu/castp/calculation.php). The benzil molecule is an 
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interesting substrate of the enzyme that reduces it to (R)-benzoin in the 
presence of NADH with excellent conversion (>99%).  
The elucidation of the ternary complex structure will ultimately provide 
details of the conformational changes in both the enzyme and the substrate 
necessary to obtain a fully productive state which guarantees high 
enantioselectivity. Nonetheless, the modelling explains the 
enantioselectivity of the benzil reduction. Several attempts were performed 
to crystallize a ternary complex of the enzyme bound to a benzil molecule, 
but they were unsuccessful. To envision how the enzyme binds the 
substrate and to probe the stereoselectivity of the hydride transfer we have 
manually modelled the benzil molecule in the active site. The starting 
structure for the alpha-diketone modeling was the crystal structure present 
in the small molecule structure database (Allen 2002). This structure shows 
a conformation of the molecule with the two aromatic rings forming a 
dihedral angle of 114° around the diketo bond. A single benzil carbonyl 
group is bonded to two substituents: a smaller phenyl group and a larger 
carbophenyl group. In order to obtain a (R)-alcohol, the hydride has to be 
added to the Si-face of the carbonyl ketone and this means that the smaller 
group is located in deep pocket in the active site opposite to the bulky 
carboxamide group of NADH (Fig. 30).  
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A rigid docking of the benzil compound performed by the patchdock server 
identifies an orientation in the substrate site which is consistent with the 
stereoselectivity of the reduction reaction leading to (R)-benzoin. However, 
it has to be noted that in the best docked conformational ensemble of 
benzil, the carbonyl C atom, to be attacked by hydride, is still rather far 
from the hydrogen at the NADH C4 position (>5.5 Å). In addition, the 
oxygen atom of the carbonyl is not hydrogen bonded to the catalytic 
Tyr158 side chain (4.7 Å apart) as expected in case of a fully productive 
state of the enzyme–substrate complex. Due to the steric hindrance of the 
benzil molecule an efficient accommodation in the substrate site would 
require a structural rearrangement of residues from the three segments 
(193–221, 96–101, and 152–155) which line the site and/or a change in the 
conformation of the diketone. A better packing of benzil in the site can be 
indeed obtained when the torsional angle around the carbon–carbon bond 
linking the two carbonyl moieties is reduced to values around 80–90°. 
Although approximate, this manually docked substrate position identifies a 
small pocket deep into the active site (Fig. 30) which is lined by Ser145, 
Leu146, Ala147, Tyr158, Phe153, Ala154 and Gly189.  
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Figure 30. Surface representation of a single chain of SaADH2. The NADH molecule is 
highlighted in magenta, as both stick and surface representations. The black arrow 
indicates the channel by which the nicotinamide ring is accessible. The green box is a 
close-up view of the binding site with the benzil molecule (in orange) manually docked 
into it. The figure was prepared using the PyMOL software (www.pymol.org). 
 
This pocket can accommodate the small phenyl group of benzil. Indeed, 
this phenyl ring would display mostly favourable contacts with Phe153, 
Ile146 and Ala147; the phenyl ring lies with its ring between two main-
chain oxygen atoms from residues Phe153 and Glu189. On the other hand, 
the large carbophenyl group of benzil would point toward the channel 
opened to the solvent (Fig. 30) and lined by Met96, Thr190, Ile195, 
Gly196, Leu197, Leu210 and Met214 (Fig. 29). However, this bulky 
carbophenyl group would display steric clashes with the NADH and 
Thr190 when the intercarbonyl dihedral angle is about 80°. Some bad 
contacts can be relieved by a deviation of the phenyl group from the plane 
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defined by the carbonyl moiety as well as by small rearrangements of the 
carboxyamide group of the nicotinamide ring (Fig. 30). Conformational 
rearrangements with respect to the crystal structure of benzil can be 
accessible at a reasonable energetic cost since both experimental and 
theoretical studies have indicated a significant flexibility of the molecular 
structure even depending on the environmental conditions (Pawelka et al. 
2001; Lopes et al. 2004). The presence of the deep pocket in the active site, 
well suited for an aromatic ring, also explains why, in the case of 
acetophenone and its derivatives, the alcohol obtained by the reduction 
reaction is the (S)-enantiomer. Indeed, the deep pocket in the active site, 
well suited for an aromatic ring, can efficiently accommodate the phenyl 
group of the acetophenone whereas the methyl group can point toward the 
channel; this orientation of the substrate in the site leads to the (S)-1-
phenylethanol product (Table 14).  
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Conclusion 
A new short-chain dehydrogenase from S. acidocaldarius was identified 
and overexpressed. The purified enzyme was shown to possess remarkable 
thermal resistance as well as high enantioselectivity on the aryl diketone 
benzil molecule. It shows many advantages with regard to its preparative 
application: ease of purification, preservability of the biocatalyst and 
absolute preference for NAD(H). It is also amenable for coupling with a 
thermophilic bacillar ADH (BsADH) in an efficient and sustainable 
bioconversion process based on coenzyme recycling, where both enzymes 
have only the coenzyme as cosubstrate. 
The remarkable resistance of SaADH2 to organic solvents proves the 
sturdiness of this biocatalyst and suggests exploratory investigations on 
conversions of poorly water-soluble prochiral substrates. In addition, the 
availability of the crystal structure of the enzyme provides the opportunity 
to rationalize the stereospecificity and stereoselectivity of the enzyme and 
to design proper mutations to broaden the scope of possible substrates. 
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Synthesis of cinnamyl alcohol from cinnamaldehyde 
with Bacillus stearothermophilus alcohol 
dehydrogenase as the isolated enzyme and in 
recombinant E. coli cells 
 
 
 
Cinnamyl alcohol 
Cinnamyl alcohol (CMO) is a versatile chemical 
due to its aroma and its fixative properties; it is used in the fragrance and 
flavouring industries for cinnamon notes and the rounding off of fruit 
aromas. It may be found in fragrances used in decorative cosmetics, fine 
fragrances, shampoos, toilet soaps and other toiletries as well as in non-
cosmetic products such as household cleaners and detergents. 
It is also a valuable intermediate for the production of aroma-relevant esters 
(Fahlbusch  et al. 2008) the syntheses of the Taxol’s C13 side chain 
(Bonini and Righi 1994), the antibiotic Chloromycetin (Eilerman 1992) and 
the antidepressant reboxetine mesylate (Henegar et al. 2007). 
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Production of cinnamyl alcohol 
CMO can be prepared by chemical reduction of cynnamaldehyde (CMA) 
under different heterogeneous catalysis conditions (Gallezot and Richard 
1998; Machado 2008) (Fig. 31).  
 
 
 
 
                                                                              unsaturated alcohol  
Figure 31.  Chemical reduction of cynnamaldehyde. 
 
However, selective hydrogenation of C=O over C=C is still an important 
issue since, besides the desired unsaturated alcohol, the process can lead to 
non-desirable saturated aldehyde and alcohol as side-products that may 
result in odour performance issues. Moreover, the use of extreme 
operational conditions and hazardous chemicals lead to serious operational 
and economic concerns. Noteworthy, the perception of smell is an 
enantioselective process; so, it frequently occurs that the different 
stereoisomers of an odorant induce quite different sensorial reactions, i.e., 
they have a different scent. In fact, the opposite enantiomers of an odorant 
CHO
CH2OH
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2
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may show odor profiles that are different in both quality and intensity 
(Ciappa et al. 2008).  
Biocatalysis provides a valuable alternative to achieve improvements 
addressing the above mentioned issues. 
 
Biocatalytic production of cinnamyl alcohol 
During the third year of my PhD project, the main focus was to study a 
suitable synthesis of CMO by means of enzymatic reduction of CMA under 
smooth and environmentally friendly conditions using the alcohol 
dehydrogenase from Bacillus stearothermophilus both as an isolated 
enzyme, and in recombinant E. coli whole cells.  
 
Alcohol dehydrogenases from Bacillus stearothermophilus  (BsADH) 
BsADH is a Zn-containing, homotetrameric, NAD(H)-dependent, and 
medium chain ADH identified in the moderate thermophilic bacterium 
Bacillus stearothermophilus LLD-R strain (BsADH, Fig. 32), cloned and 
expressed in E. coli (Cannio et al. 1994; Guagliardi et al. 1996). 
This ADH has been successfully applied to hydrogen tunnelling effect 
studies across a broad temperature range (Kohen et al. 1999), as well as in 
structural and molecular dynamic studies (Ceccarelli et al. 2004;  Zhang 
and Bruice 2007). BsADH is NAD(H)-dependent and is mainly active on 
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aliphatic and aromatic primary and secondary alcohols and aldehydes, but 
not on aliphatic and aromatic ketones (Guagliardi et al 1996). These 
requisites make BsADH a versatile auxiliary enzyme suitable for NADH 
regeneration in the well-established enzyme-coupled approach for redox 
bioconversion processes, which utilize isolated enzymes or whole cells (De 
Wildeman et al. 2006; Berenguer-Murcia and Fernandez-Lafuente 2007; 
Hall and Bommarius 2011). In fact, BsADH was recently proved to 
efficiently regenerate NADH in situ for the enantioselective reduction 
catalysed by Thermus thermophilus ADH of different aromatic ketones in 
the presence of 2-propanol, methyl benzoylformate and o-chlorobenzoyl 
formate in the presence of ethanol, and for the benzil to (R)-benzoin 
reduction catalysed by Sulfolobus acidocaldarius ADH (see previous 
Sections). A feasible protocol for the synthesis of [4R-2H]NADH with high 
yield was also set up by enzymatic oxidation of 2-propanol-d8 catalyzed by 
BsADH (Pennacchio et al. 2010b). 
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Ceccarelli et al. (2004) 
Biochemistry 43:5266−5277
 
Figure 32. Overall structure of tetrameric BsADH. 
 
Biocatalytic synthesis of cinnamyl alcohol employing recombinant 
BsADH 
 
The E. coli expression system developed for BsADH in our laboratory is 
quite efficient, producing ~30 mg homogeneous enzyme per litre of culture 
with a specific activity of 250 U/mg. This easy availability and very high 
efficiency has allowed to exploit the high potential of the enzyme for 
application in bioconversion as auxiliary ADH for NADH regeneration as 
mentioned above. In the present work, BsADH plays the dual role as the 
production enzyme and as the NADH regeneration enzyme as shown in 
Scheme 3.  
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Scheme 3. Enzymatic reduction of CMA and recycling of cofactor utilizing BsADH 
and 2-propanol. 
 
The kinetic parameters for each substrate and product involved in the 
scheme reactions were determined in order to analyse the cofactor 
regeneration system as a whole (Table 15).  
 
Table 15. Steady-state kinetic constants of BsADH  
Substrate kcat 
(s─1) 
Km 
(mM) 
kcat/Km 
(s─1 mM─1) 
CMA 55 0.03 1,835 
CMO 43 0.11 391 
2-Propanol 287 57.8 5 
Acetone NA [a]   
NADH 43 0.016 2,687 
NAD+ 33 0.45 73 
                                                                   [a]
 NA, no measurable activity. 
 
BsADH displays higher catalytic efficiency with CMA and NADH than 
with CMO and NAD+ and a relatively very low catalytic efficiency in 2-
propanol oxidation, but shows no activity on the corresponding co-product 
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acetone. This suggests that the preferred reaction catalyzed by BsADH is 
the CMA reduction compared to the reverse reaction, and that the reduction 
of NAD+ could be favourably driven to NADH formation in the presence of 
a relatively high excess of the co-substrate 2-propanol. Thus the 
regeneration reaction is practically irreversible and relatively straight 
forward. The experimental conditions, including buffer, pH, and 
temperature were chosen to optimize the productivity of the bioconversion 
process. Previous studies indicated that the optimal pH for the reduction 
reaction is 6.0, and 8.0–8.5 for the oxidation reaction, and that the optimal 
temperature is around 63°C (Guagliardi et al. 1996). Due to instability of 
the reduced cofactor under acidic conditions, neutral pH was chosen as a 
compromise between cofactor stability and BsADH activity at suboptimal 
pH. Moreover a reaction temperature of 50°C was chosen, since BsADH is 
highly active and retains full activity over 24 h at this temperature. Table 
16 summarizes the results of a study carried out to optimize the production 
of CMO in analytical scale by changing several parameters, time and 
enzyme, 2-propanol and cofactor concentrations. The results of entries 1–3 
suggest that the 2-propanol concentration plays a critical role in the enzyme 
efficiency in the CMA bioconversion.  
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                            [a]
 Values in parentheses refer to reactions carried out for 6 h. 
                            [b]
 Reaction time, 24 h 
 
The reduction of 0.125 mg of CMA in the presence of 5% 2-propanol was 
95 and 97% after 3 and 6 h, respectively, and 99% in the presence of 10% 
2-propanol after both 3 and 6 h. However, the reaction performed in the 
presence of 15% 2-propanol yielded CMO with a conversion of 83 and 
85% after 3 and 6 h, respectively, presumably due to excess-substrate 
inhibition or low stability of NAD+ in the presence of relatively elevated 
concentrations of 2-propanol (Schroer et al. 2009), or both. By doubling the 
cofactor concentration, the conversion decreased slightly in 3 h (96%), but 
reached 99% in 6 h reaction (entry 4). Bioconversions were then carried out 
in the presence of 1 mM NAD+ at 8-fold higher substrate concentration 
(entry 5). The level of conversion was 98% following 3 and 6 h of reaction 
and remained the same using lower amounts of enzyme (entry 6). However, 
a further 10-fold decrease in enzyme concentration resulted in nearly 50% 
Table 16. Analytical-scale bioreduction of CMA by isolated BsADH 
Entry 2-Propanol 
(%) 
CMA 
(mg mL–1) 
BsADH 
(mg mL–1) 
NAD+ 
(mM) 
Time [a] 
(h) 
Conversion [a] 
(%) 
1 5 0.125 0.12 1 3 (6) 95 (97) 
2 10 0.125 0.12 1 3 (6) 99 (99) 
3 15 0.125 0.12 1 3 (6) 83 (85) 
4 10 0.125 0.12 2 3 (6) 96 (99) 
5 10 1.0 0.12 1 3 (6) 98 (98) 
6 10 1.0 0.05 1 3 (6) 98 (98) 
7 10 1.0 0.005 1 3 (24) [b] 54 (60) [b] 
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conversion in 3 h and only slightly higher at reaction times as long as 24 h 
(entry 7). Therefore, based on data of entry 6, 0.05 mg mL–1 enzyme and 1 
mg mL–1 substrate were chosen as tentative concentration values to scale 
the bioreduction process up to one hundred fold the amount of CMA.  
Table 17 (entry 1) shows that the bioreduction of 100 mg CMA occurred 
with 94% conversion in 3 h, at a temperature of 50°C, using 10% 2-
propanol and 1 mM NAD+ in aqueous buffer, pH 7.0. 
 
              Table 17. Lab-scale bioreduction of CMA by isolated BsADH  
Entry Volume 
(mL) 
CMA 
(gL–1) 
CMA 
(mg) 
BsADH 
(mg mL–1) 
Time 
(h) 
Conversion  
(%) 
Yield  
(%) 
1 100 1 100 0.05 3 94 ND [a] 
2 200 0.5 100 0.05 3 99 75 
3 200 0.5 100 0.01 3 99 77 
4 400 0.5 200 0.01 3 97 88 
                            [a]
 ND, not determined 
 
However, when the same reaction was carried out in double the reaction 
volume, a conversion nearing 100% was achieved (entry 2). Diluting the 
substrate by half was successfully applied to the reduction of 100 mg 
substrate performed in the presence of five-fold lower enzyme 
concentration (entry 3). A 99% conversion and 77% yield was obtained. 
Analogously, 97% conversion was achieved from reduction of twice the 
amount of substrate (entry 4); in this case, extractive downstream-
processing yielded the desired product CMO to high purity (≥98% by NMR 
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spectral data) with a yield of 88%, which corresponds to the productivity of 
0.44 g L–1 (weight of isolated product per liter of initial reaction volume) 
and 50 g/g enzyme.  
Since scaling up the bioconversion of over 200 mg of CMA (4 mM) would 
have required a work up of very significant volumes and large amounts of 
homogeneous enzyme, we further explored the applicative potential of 
BsADH by incorporating it directly into recombinant E. coli cells. 
 
Biocatalytic synthesis of cinnamyl alcohol employing recombinant E. 
coli/BsADH 
 
E. coli RB791 cells harboring BsADH showed an activity of 43 U/mg, 
which was about 6-fold less than that of homogeneous enzyme. Control 
experiments using non-transformed cells and non-induced transformed 
cells were carried out to ascertain whether any dehydrogenases/reductase 
was present in the E. coli strain which was active on CMA and CMO. No 
conversion was observed suggesting that no NAD(H) dependent ADH, if 
any, was active on CMA and CMO under the experimental conditions used 
(data not shown).  
Table 18 summarizes the results of a study on CMA microbial reduction 
with recombinant E. coli/BsADH cells by keeping constant the substrate 
concentration and increasing the reaction volumes.  
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        Table 18. Lab-scale bioreduction of CMA by recombinant E. coli/BsADH cells  
Entry Volume 
(mL) 
CMA 
(g L–1) 
CMA 
(mg) 
Cells 
(mg mL–1) 
Time 
(h) 
Conversion 
(%) 
Yield 
(%) 
1 10 12.5 125 200 3 97 79 
2 20 12.5 250 200 3 98 78 
3 40 12.5 500 200 3 69 ND [a] 
4 40 12.5 500 200 6 95 81 
5 40 12.5 500 300 3 95 73 
6 80 12.5 1000 300 6 97 82 
            
[a]
 ND, not determined 
 
The bioreduction of 125 mg of CMA at 37°C for 3 h resulted in 97% 
conversion, as determined by HPLC analysis. The subsequent work-up 
gave 98.7 mg of highly pure product (≥98% by NMR, data not shown). A 
similar result was obtained with twice the amount of substrate (entry 2). 
However, by further doubling of the CMA amount, the conversion 
decreased from 98% to 69% (entry 3), most likely due to catalyst 
deficiency or short reaction time; the same reaction carried out doubling the 
reaction time (entry 4) or increasing by 1.5-fold the cell concentration 
(entry 5) significantly improved the system efficiency, resulting in 95% 
conversion in both cases. This combination of reaction time and cell 
concentration turned out to be suitable for converting 1 g (94 mM) of 
substrate. An excellent conversion and a more than satisfactory yield of 
82% was obtained (entry 6), which corresponds to the productivity of 34 
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g/gwet cell weight and 10.25 g L–1, i.e. 23-fold higher with respect to that 
obtained by the isolated enzyme (Table 17). 
Due to the high conversion levels, additional amounts of cofactor were not 
necessary. Presumably, the levels of oxidized and reduced cofactor in the 
recombinant E. coli are high enough to saturate the substrate-coupled 
system (Scheme 3). This may be explained by the fact that the total 
intracellular cofactor concentration in E. coli, which is around 2.6 mM 
NAD+ and 0.083 mM NADH (Bennett et al. 2009) and the Km values of 
BsADH for NAD+ and NADH, which are 0.45 mM and 0.016 mM 
respectively (Table 15).  
Permeabilization of E. coli cell was not pursued due to the high yield of the 
microbial reductions described above. Presumably, the exposure to a large 
amount of aromatic substrate and 2-propanol at relatively long reaction 
times and high temperatures partially permeabilizes the cell wall (as 
reported for example in (Cánovas et al. 2005)), to a sufficient degree to 
facilitate mass transfer. Furthermore, it is worthy of note the remarkable 
stability of the microbial catalyst under the experimental conditions used in 
the presence of relatively high substrate/product concentrations. A widely 
held notion is that the synthetic reductase is oftentimes more stable within 
the cellular environment as compared to the isolated enzyme (Goldberg et 
al. 2007; Kratzer et al. 2008). 
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Conclusion  
In this study, the enzymatic synthesis of cinnamyl alcohol, a versatile fine 
chemical, has been developed in a one phase-system, using a whole-cell 
biocatalyst that is based on an E. coli strain expressing a thermophilic 
NAD(H)-dependent ADH from Bacillus stearothermophilus to a high level 
of activity. The enzyme regenerates by itself the endogenous reductase 
cofactor NADH without requiring expensive additional cofactor, in the 
presence of cheap sacrificial substrate 2-propanol as hydrogen donor. The 
method is characterized by favourable thermodynamics since 
alcohol/ketone does not interfere with the synthesis reaction, and gives 
CMO with high yield and purity. Taken together, our study points out the 
advantage of whole cell biocatalyst in comparison to isolated enzyme 
thanks to its ease of preparation, cofactor cost, simplified work-up, and 
good productivity; it also demonstrates that the optimized microbial 
process can be implemented on a larger preparative scale using suitable 
reaction times and cell concentrations. These features, in addition to 
effective in-vivo cofactor regeneration system, are valuable prerequisites 
for the commercial viability of a biotechnological process.  
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MATERIALS and METHODS 
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Chemicals  
NAD(P)+ and NAD(P)H were obtained from AppliChem. (Darmstadt, 
Germany). Alcohols, aldehydes, ketones and keto esters were obtained 
from Sigma-Aldrich. MES {2-(N-morpholino) ethanesulfonic acid} was 
obtained from Sigma Chemical Co. (St. Louis, MO). Aldolase was 
obtained from Amersham Biosciences. Dimethylsuberimidate (DMS) and 
dimethyladipimate (DMA) chemical cross-linkers were from Pierce. 
Methyl o-chlorobenzoylformate and 1-Phenylethanol-d9 
[C6D5CD(OH)CD3] were obtained from Ricci Chimica (Perugia, Italy). 1-
Butyl-3-methylimidazolium tetrafluoroborate (BMIMBF4) was a kind gift 
from Professor S. Cacchi. Other chemicals were A grade substances from 
Applichem. Solutions of NAD(P)H and NAD(P)+ were prepared as 
previously reported (Pennacchio et al. 2008). All solutions were made up 
with MilliQ water. 
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TtADH Material and Methods 
Enzymes and kinetic assays 
Recombinant Thermus thermophilus ADH (TtADH) and recombinant 
Bacillus stearothermophilus LLD-R strain (BsADH) were prepared as 
described previously (Pennacchio et al. 2008). Glucose dehydrogenase 
from Thermoplasma acidophilum (TaGDH) was from Sigma, St. Luis, MO.  
TtADH activity was assayed spectrophotometrically at 65°C by measuring 
the change in absorbance of NADH at 340 nm using a Cary 1E 
spectrophotometer equipped with a Peltier effect-controlled temperature 
cuvette holder. The kinetic parameters of TtADH for α-keto esters were 
determined as described previously (Pennacchio et al. 2008). TaGDH was 
assayed at 50°C by measuring the change in absorbance of NADPH at 340 
nm. The standard assay was performed by adding 0.25 µg of enzyme to 1 
mL of preheated assay mixture containing 50 mM glucose and 0.4 mM 
NADP+ in 50 mM sodium phosphate, pH 7.0. 
 
 The effect of organic solvents on TaGDH was investigated by incubating 
0.025 mg mL–1 protein in 50 mM sodium phosphate, pH 7.0, at 50°C, in the 
absence and presence of organic solvents. At specific time intervals, the 
samples were centrifuged and small aliquots were withdrawn and assayed. 
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The volume of solution in the tight capped test tube did not change during 
incubation. 
 
Procedure for bioreduction 
Bioreduction of α-keto esters was performed at 50°C using two NADH 
regeneration systems. The first consisted of TaGDH and glucose. For 
analytical biotransformation the reaction mixture contained 6.2 mM 
carbonyl compound, 1 mM NAD+, 50 mM glucose, 25 µg TtADH, and 5.5 
µg TaGDH in 0.2 mL of 100 mM sodium phosphate, pH 7.0. Semi-
preparative reactions were performed on a 0.1 g scale in a reaction volume 
up to 10 mL, using 0.05 mg mL–1 TtADH, and 0.01 mg mL–1 TaGDH. 
During the reaction the pH was maintained at pH 6.5–7.0 with the addition 
of a 2 M NaOH solution.  
The second NADH regeneration system consisted of BsADH and 2-
propanol or different linear alcohols as described previously (Pennacchio et 
al. 2008) with some modifications. The reaction mixture contained 6.2 mM 
carbonyl compound, 1 mM NAD+, 15 µg of BsADH, 0.6 to 4% v/v alcohol 
substrate, and 125 µg TtADH in 1 mL of 100 mM sodium phosphate, pH 
7.0, 0,5 mM 2-mercaptoethanol and 100 mM KCl. Semi-preparative 
reactions were performed on a 0.1 g scale in a reaction volume up to 10 
mL, using 0.05 mg mL–1  TtADH, and 0.01 mg mL–1 BsADH. In both 
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systems the mixtures were shaken at 160 rpm for different reaction times in 
a temperature-controlled water bath. Upon termination of the reaction, the 
mixtures were extracted twice with ethyl acetate, dried with anhydrous 
Na2SO4 and concentrated under reduced pressure. The samples were 
prepared in hexane/2-propanol (9:1) for HPLC analysis. 
To determine the isolated yield of the semi-preparative reactions carried 
out using the two NADH regeneration systems, the ethyl acetate extracts 
were dried with anhydrous Na2SO4, filtered, and concentrated under 
reduced pressure. Purification by silica gel column chromatography 
(hexane/ethyl acetate, 9:1) gave methyl (R)-mandelate or methyl (R)-o-
chloromandelate as colourless oils; yield: 77 mg (77% isolated yield; 
conversion: 78%) and 81 mg (81%; 99%) of methyl (R)-mandelate 
produced by the TtADH/TaGDH and TtADH/BsADH system, 
respectively; 86 mg (86% isolated yield; conversion: 96%) and 78 mg 
(78%; 98%) of (R)-o-chloromandelate produced by TtADH/TaGDH and 
TtADH/BsADH system, respectively. 
The degree of conversion and enantiomeric purity of the products were 
determined on the basis of the peak areas of ketone substrates and alcohol 
products separated and visualized by HPLC, on a Chiralcel OD-H column 
(Daicel Chemical Industries, Ltd., Osaka, Japan). The absolute 
configuration of product alcohols was determined by comparing the HPLC 
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data with standard samples. Products were analyzed with isocratic elution 
under the following conditions: hexane/2-propanol (9:1) (mobile phase), 
flow rate of 1 mL min–1, detection for bioconversions of MBF and ClMBF 
at 210 nm. At this wavelength, both MBF and methyl (R)-mandelato as 
well as ClMBF and methyl (R)-o-chloromandelate have the same molar 
extinction coefficient values, so that areas of substrates and products are 
equally proportional to concentrations. Retention times were as follows: 
6.14, 8.82 and 14.15 min for MBF, methyl (S)-mandelate and methyl (R)-
mandelate, respectively; 6.92, 10.12 and 17.16 min for ClMBF, methyl (S)-
o-chloromandelate and methyl (R)-o-chloromandelate, respectively. The 
absolute stereochemistry of the two halogenated alcohol enantiomers were 
assigned by comparison to the values described in the literature for methyl 
o-chloromandelates (Ema et al. 2008). The log P values were obtained 
from Laane and coworkers (1987). 
 
Optimal reaction time and concentration determination  
The reactions were carried out at 50°C in 50 mM sodium phosphate, pH 
7.0, 100 mM KCl and NADH regeneration system of TaGDH and glucose. 
Reaction volume, 0.2 mL; TtADH and TaGDH 25 and 5.5 µg, respectively; 
NAD+, 1.0 mM; MBF, 1.0 g L–1; glucose, 50 mM. The reactions were 
stopped by addition of ethyl acetate at the times indicated. The dried 
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extracts were analysed by chiral HPLC and the relative conversion 
calculated as the area of alcohol products divided by the total area.  
The reactions were carried out for 24 h under same conditions as above at 
increasing substrate concentrations in the absence and presence of 5% v/v 
acetonitrile and 20% v/v hexane. 
 
Effect of the BsADH alcohol substrates on the enantioselectivity and 
efficiency of the reduction catalysed by TtADH.  
 
The reactions were carried out for 24 h at 50°C in presence of 4% v/v 
alcohol, in buffer, 100 mM sodium phosphate, pH 7.0, 100 mM KCl, 5 mM 
2-mercaptoethanol. Reaction volume, 10 mL; TtADH and BsADH 
concentrations, 0.05 and 0.01 mg mL–1, respectively; 1 mM NAD+; MBF 
10 g L–1. The relative conversion was determined by HPLC {Chiralcel OD-
H, hexane/iPrOH [(9:1)]}.  
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SaADH Material and Methods 
Amplification and cloning of the saadh gene 
Chromosomal DNA was extracted by caesium chloride purification as 
described by Sambrook et al. (1989). Ethidium bromide and caesium 
chloride were removed by repeated extraction with isoamyl alcohol and 
extensive dialysis against 10 mM Tris–HCl pH 8.0, 1 mM EDTA, 
respectively. DNA concentration was determined spectrophotometrically 
at 260 nm, and the molecular weight was checked by electrophoresis on 
0.8% agarose gel in 90 mM Tris–borate pH 8.0, 20 mM EDTA, using DNA 
molecular size markers. The saadh gene was amplified by polymerase 
chain reaction (PCR) using oligonucleotide primers based on the saadh 
sequence of Sulfolobus acidocaldarius strain DSM 639 (GenBank 
accession no. YP_256716.1). The following oligonucleotides were used: 
50-GGTTGGCATATGGACATTGATAGGCTCTTTTCAGTA-30 as the 
forward primer (the NdeI restriction site is underlined in the sequence) and 
the oligonucleotide 50-GGTTGGGAATTCCTACACCTTTGGGTCATA 
TCTACCATCTA-3 as the reverse primer. This latter oligonucleotide 
introduces a translational stop following the last codon of the ADH gene, 
followed by an EcoRI restriction site, which is underlined in the sequence 
shown. The PCR product was cloned into the expression vector pET29a 
(Novagen, Madison, WI, USA) and digested with the appropriate 
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restriction enzymes to create pET29a-saADH. The insert was sequenced in 
order to verify that mutations had not been introduced during PCR. 
 
Expression and purification of recombinant SaADH 
Recombinant protein was expressed in E. coli BL21(DE3) cells (Novagen) 
transformed with the corresponding expression vector. Cultures were 
grown at 37°C in 2 L of LB medium containing 30 µg mL-1 kanamycin. 
When the A600 of the culture reached 1.4, protein expression was induced 
by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a 
concentration of 1.0 mM. The bacterial culture was incubated at 37°C for a 
further 24 h. Cells were harvested by centrifugation, and the pellet was 
stored at −20°C until use. The cells obtained from 2 L of culture were 
suspended in 20 mM Tris–HCl buffer (pH 7.5) containing 0.1 mM 
phenylmethylsulfonyl fluoride (PMSF) and were lysed using a French 
pressure cell (Aminco Co., Silver Spring, MD) at 2,000 psi (1 psi = 6.9 
kPa). The lysate was centrifuged, and the supernatant was incubated in the 
presence of DNase I (50 µg per mL of solution) and 5 mM MgCl2 for 30 
min at 37°C, followed by protamine sulphate (1 mg per mL of solution) at 
4°C for 30 min. The nucleic acid fragments were removed by 
centrifugation, and the supernatant was incubated at 75°C for 15 min. The 
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host protein precipitate was removed by centrifugation. The supernatant 
was dialysed overnight at 4°C against 20 mMTris–HCl, pH 8.4 (buffer A) 
containing 1 mM PMSF. The dialysed solution was applied to a DEAE-
Sepharose Fast Flow (1.6 x 12 cm) column equilibrated in buffer A. After 
washing with 1 bed volume of the same buffer, elution was performed with 
a linear gradient of 0–0.06 MNaCl (80 mL of each concentration) in buffer 
A, at a flow rate of 60 mL h-1. The active pool was dialysed against buffer 
A, concentrated fivefold with a 30,000 MWCO centrifugal filter device 
(Millipore), and applied to a Sephadex G-75 (1.6 x 30 cm) column 
equilibrated in buffer A containing 0.15 MNaCl. The active pool was 
dialysed against buffer A and concentrated to obtain 2.5 mg protein mL-1 as 
described previously. SaADH was stored at -20°C, without loss of activity 
following several months of storage. SDS-PAGE and non-denaturing 
PAGE were carried out according to the Laemmli method (1970), with 
minor modifications (Raia et al. 2001). The subunit molecular mass value 
was determined by electrospray ionization mass spectrometry (ESI-MS) 
with a QSTAR Elite instrument (Applied Biosystems, USA). The protein 
concentration was determined with a Bio-Rad protein assay kit using BSA 
as a standard. 
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Size-exclusion chromatography 
Molecular masses were determined by size-exclusion chromatography 
using a Superdex 200 10/300 GL column (Amersham Biosciences), 
equilibrated with 50 mM Tris–HCl, pH 9.0, containing 0.15 M NaCl, at a 
flow rate of 0.5 mL min-1. The following molecular mass standards were 
used for calibration: vitamin B12 (1,350 Da), horse myoglobin (17.5 kDa), 
chicken ovalbumin (44 kDa), beef γ-globulin (158 kDa), and thyroglobulin 
(670 kDa) from Bio-Rad. In order to calculate the distribution coefficient, 
the void and total volumes of the column were determined with blue 
dextran and tryptophan, respectively. 
 
Chemical cross-linking 
Cross-linking reactions of SaADH with DMA and DMS were conducted 
for 1 h at 25°C in a 25-µ volume of 0.1 M triethanolamine–HCl, pH 8.5 at 
0.20 mg mL-1 protein, and 0.1 mg mL-1 bifunctional reagent. The molecular 
mass of cross-linked SaADH species was estimated by SDS-PAGE 
according to the procedure described by Davies and Stark (1970). 
 
Enzyme assay 
SaADH activity was assayed spectrophotometrically at 65°C by measuring 
the change in absorbance of NADH at 340 nm using a Cary 1E 
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spectrophotometer equipped with a Peltier effect-controlled temperature 
cuvette holder. The standard assay for the reduction reaction was 
performed by adding 5–25 µg of the enzyme to 1 mL of preheated assay 
mixture containing 25 mM ethyl benzoylformate (EBF) and 0.3 mM 
NADH in 37.5 mM MES–NaOH, pH 5.5. The standard assay for the 
oxidation reaction was performed using a mixture containing 25 mM 
cycloheptanol and 5 mM NAD+ in 25 mM sodium phosphate, pH 8.0. 
Screening of the substrates was performed using 1 mL of assay mixture 
containing either 10 mM alcohol and 5 mM NAD+ in 25 mM sodium 
phosphate, pH 8.0, or 10 mM carbonyl compound and 0.1 mM NADH in 
37.5 mM MES–NaOH, pH 5.5. One unit of SaADH represented 1 µmol of 
NADH produced or utilized per min at 65°C, on the basis of an absorption 
coefficient of 6.22 mM-1 cm-1 for NADH at 340 nm. 
 
Effect of pH on activity 
The optimum pH values for the reduction and oxidation reactions were 
determined at 65°C under the conditions used for EBF and cycloheptanol, 
respectively, except that different buffer systems were used. The pH was 
controlled in each assay mixture at 65°C. 
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Kinetics 
The SaADH kinetic parameters were calculated from measurements 
determined in duplicate or triplicate and by analysing the kinetic results 
using the program GraFit (Leatherbarrow 2004). The turnover value (kcat) 
for SaADH was calculated on the basis of a molecular mass of 29 kDa, 
assuming that the four subunits are catalytically active. 
 
Thermophilicity and thermal stability 
SaADH was assayed in a temperature range of 30–95°C using standard 
assay conditions and 22 µg of protein mL-1 of assay mixture. The stability 
at various temperatures was studied by incubating 0.2–mg mL-1 protein 
samples in 50 mM Tris–HCl, pH 9.0 at temperatures between 25 and 95°C 
for 30 min. Each sample was then centrifuged at 5°C, and the residual 
activity was assayed as described above. Long-term stability was studied 
by incubating protein samples (0.2 mg mL-1) in 50 mM Tris–HCl, pH 9.0, 
at 50 and 70°C, or in 50 mM Tris–H3PO4, pH 7.0 at 50 and 60°C and the 
residual activity was assayed after 6 and 24 h as described above. The 
effect of chelating agents on enzyme stability was studied by measuring the 
activities before and after exhaustive dialysis of the enzyme against buffer 
A, containing 1 mM EDTA, and then against buffer A alone. An aliquot of 
the dialysed enzyme was then incubated at 70°C in the absence and 
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presence of 1 mM EDTA or o-phenanthroline, and the activity was assayed 
at different times. 
 
Effects of compounds on enzyme activity 
The effects of salts, metal ions, and chelating agents on SaADH activity 
were investigated by assaying the enzyme in the presence of an appropriate 
amount of each compound in the standard assay mixture used for the 
oxidation reaction. The effects of organic solvents were investigated by 
measuring the activity in enzyme samples (0.5 mg mL-1 in 100 mM MES, 
pH 6.0, 5 mM 2-mercaptoethanol) immediately after the addition of 
organic solvents at different concentrations, and 6 and 24 h of incubation at 
50°C. The percentage activity for each sample was calculated by 
comparison with the value measured prior to incubation. The volume of the 
solution in a tightly capped test tube did not change during incubation. 
 
Enantioselectivity 
The enantioselectivity of SaADH was determined by examining the 
reduction of bicyclic ketones and α-keto esters using an NADH 
regeneration system consisting of glucose and glucose dehydrogenase from 
Thermoplasma acidophilum (TaGDH) (Sigma, St. Louis, MO). The 
reaction mixture contained 1 mM NAD+, 5–10 mM carbonyl compound, 50 
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mM glucose, 125 µg SaADH, and 25 µg of TaGDH in 1 mL of 50 mM 
Tris–H3PO4, pH 7.0. The reactions were carried out at 50°C at different 
times in a temperature-controlled water bath. Upon termination of the 
reaction, the reaction mixture was extracted twice with ethyl acetate. The 
conversion yield and enantiomeric purity of the product were determined 
on the basis of the peak areas of ketone substrates and alcohol products by 
HPLC, on a Chiralcel OD-H column (Daicel Chemical Industries Ltd., 
Osaka, Japan). The absolute configuration of product alcohols was 
identified by comparing the chiral HPLC data with the standard samples. 
Products were analysed with isocratic elution, under the following 
conditions: hexane/2-propanol (9:1) (mobile phase), flow rate of 1 mL min-
1, detection at 210 nm for bioconversions of methyl and ethyl 
benzoylformate and for methyl o-chlorobenzoylformate; hexane/2-propanol 
(95:5), flow rate of 1 mL min-1, detection at 217 nm for 1-indanone. 
Retention times were the following: 5.7, 8.1 and 13.4 min for methyl 
benzoylformate, methyl (S)-mandelate and methyl (R)-mandelate; 5.5, 7.4 
and 12.1 min for ethyl benzoylformate, ethyl (S)-mandelate and ethyl (R)-
mandelate; 6.9, 8.8 and 9.7 min for methyl o-chlorobenzoylformate, methyl 
(R)-o-chloromandelate and methyl (S)-o-chloromandelate; 8.8, 9.7, 10.8 
min for 1-indanone and (S)- and (R)-1-indanol, respectively. 
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Coenzyme stereospecificity determination 
The SaADH stereospecificity was investigated by NMR analysis of NADD 
obtained from the reaction of NAD+ with 1-phenylethanol-d9. The reaction 
mixture contained 2.0 mmol 1-phenylethanol-d9, 30 µmol NAD+, 26 units 
of SaADH and 0.25 mmol sodium phosphate buffer (pH 8.0) in a total 
volume of 5 mL. The reaction proceeded at 50°C while monitoring at 340 
nm. When the A340 of the mixture reached a maximum (after 4 h), the 
solution was cooled and then applied to a DEAE-FF Sepharose column 
(1.6 x 8 cm) previously equilibrated with 10 mM sodium phosphate buffer 
(pH 8.0). The column was washed enough with the same buffer and then 
NADD was eluted with 20 mM sodium phosphate buffer (pH 8.0) 
containing 20 mM NaCl. Fractions with value of A260/A340 ratio B2.3 were 
collected and the pool (8.2 µmol of NADD) was lyophilized for 1H-NMR 
analysis. 1H-NMR spectra were recorded on a Bruker cryoprobeTM Avance 
DRX instrument operating at 600 MHz. Samples were dissolved in 
0.5 mL of D2O. Chemical shifts were given in ppm (δ) scale; the HDO 
signal was used as the internal standard (δ 4.68). 
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SaADH2 Material and Methods 
Amplification and cloning of the saadh2 gene 
Chromosomal DNA was extracted by caesium chloride purification as 
described by Sambrook et al. (1989). Ethidium bromide and caesium 
chloride were removed by repeated extraction with isoamyl alcohol and 
extensive dialysis against 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 
respectively. DNA concentration was determined spectrophotometrically at 
260 nm, and the molecular mass checked by electrophoresis on 0.8% 
agarose gel in 90 mM Tris-borate pH 8.0, 20 mM EDTA, using DNA 
molecular size markers. The saadh2 gene was amplified by polymerase 
chain reaction (PCR) using oligonucleotide primers based on the saadh2 
sequence of Sulfolobus acidocaldarius strain DSM 639 (GenBank 
accession no. YP_255871.1). The following oligonucleotides were used: 
(5′-TGCATAGTAGCATATGTCATATCAGAGTTTG-3′) as the forward 
primer (the Nde I restriction site is underlined in the sequence) and the 
oligonucleotide (5′-AGGAATTCACATTACAGTACAGTTAAACCACC-
3′) as the reverse primer. This latter oligonucleotide introduces a 
translational stop following the last codon of the ADH gene, followed by 
an EcoRI restriction site, which is underlined in the sequence shown. The 
PCR product was digested with the appropriate restriction enzymes and 
cloned into the expression vector pET29a (Novagen, Madison, Wisconsin, 
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USA) to create the recombinant pET29a-saADH plasmid. The insert was 
sequenced in order to verify that mutations had not been introduced during 
PCR. 
 
Expression and purification of recombinant SaADH2 
Recombinant protein was expressed in E. coli BL21(DE3) cells (Novagen) 
transformed with the corresponding expression vector. Cultures were 
grown at 37°C in 2 litres of LB medium containing 30 µg mL–1 kanamycin. 
When the A600 of the culture reached 1.4, protein expression was induced 
by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to a 
concentration of 1.0 mM. The bacterial culture was incubated at 37°C for a 
further 24 h. Cells were harvested by centrifugation, and the pellet stored at 
–20°C until use. The cells obtained from 2 L of culture were suspended in 
20 mM Tris-HCl buffer (pH 7.5) containing 0.1 mM phenylmethylsulfonyl 
fluoride (PMSF) and were lysed using a French pressure cell (Aminco Co., 
Silver Spring, MD) at 2,000 p.s.i. (1 p.s.i.= 6.9 kPa). The lysate was 
centrifuged, and the supernatant incubated in the presence of DNase I (50 
µg per mL of solution) and 5 mM MgCl2 for 30 min at 37°C, followed by 
protamine sulfate (1 mg per mL of solution) at 4°C for 30 min. The nucleic 
acid fragments were removed by centrifugation, and the supernatant 
incubated at 70°C for 15 min. The host protein precipitate was removed by 
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centrifugation. The supernatant was dialysed overnight at 4°C against 20 
mM Tris-HCl, pH 8.4 (buffer A) containing 1 mM PMSF. The dialysed 
solution was applied to a DEAE-Sepharose Fast Flow (1.6 × 12 cm, 
Pharmacia) column equilibrated in buffer A at 120 mL h–1. The active pool 
did not bind to the column matrix. The flowthrough fractions were 
combined and dialysed against buffer A, concentrated 5-fold with a 30,000 
MWCO centrifugal filter device (Millipore), and applied to a Sephadex G-
75 (1.6 × 30 cm, Pharmacia) column equilibrated in buffer A containing 
150 mM NaCl. The active pool was dialysed against buffer A and 
concentrated to obtain 2.0 mg protein mL–1 as described previously. 
SaADH2 was stored at –20°C in buffer A containing 50% glycerol, without 
loss of activity following several months of storage. SDS-PAGE was 
carried out according to the Laemmli method (1970). The subunit 
molecular mass was determined by electrospray ionization mass 
spectrometry (ESI-MS) with a QSTAR Elite instrument (Applied 
Biosystems, Unites States). The protein concentration was determined with 
a Bio-Rad protein assay kit using BSA as a standard. 
 
Sucrose density gradient centrifugation 
One hundred microliters of a 1 mg mL–1 purified SaADH2 solution was 
layered on top of a 10 mL 5–20% preformed sucrose gradient in 50 mM 
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Tris-HCl, pH 8.4. The standards were also prepared by layering 100 µl of 1 
mg mL–1 chymotripsinogen (25 kDa), BSA (67 kDa), T. thermophilus 
ADH (a 108-kDa tetramer), and S. solfataricus ADH (a 150-kDa tetramer) 
on top of another identical sucrose gradient. By using a Beckman SW 41 Ti 
rotor, the tubes containing the samples were spun at 37,000 rpm for 18 h at 
4°C in a Beckman LE-80 ultracentrifuge. Immediately after centrifugation, 
gradients were collected in 250 µl-fractions and assayed for absorption at 
280 nm to determine the position of the marker protein. The mass of 
SaADH2 was estimated from the position of the peak relative to those of 
the markers. 
 
Enzyme assay 
SaADH2 activity was assayed spectrophotometrically at 65°C by 
measuring the change in absorbance of NADH at 340 nm using a Cary 1E 
spectrophotometer equipped with a Peltier effectcontrolled temperature 
cuvette holder. The standard assay for the reduction reaction was 
performed by adding 5˗25 µg of the enzyme to 1 mL of preheated assay 
mixture containing 20 mM ethyl 3-methyl-2-oxobutyrate (EMO) and 0.2 
mM NADH in 37.5 mM sodium phosphate, pH 5.0. The standard assay for 
the oxidation reaction was performed using a mixture containing 18 mM 
cycloheptanol and 3 mM NAD+ in 50 mM glycine/NaOH, pH 10.5. 
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Screening of the substrates was performed using 1 mL of assay mixture 
containing either 10 mM alcohol and 3 mM NAD+ in 50 mM 
glycine/NaOH, pH 10.5, or 10 mM carbonyl compound and 0.1 mM 
NADH in 37.5 mM sodium phosphate, pH 5.0. One unit of SaADH2 
represented 1 µmol of NADH produced or utilized per min at 65°C, on the 
basis of an absorption coefficient of 6.22 mM–1 cm–1 for NADH at 340 nm. 
 
Effect of pH on activity 
The optimum pH values for the reduction and oxidation reactions was 
determined at 65°C under the conditions used for EMO and cycloheptanol, 
respectively, except that different buffer were used. The concentration of 
each buffer solution was diluted to get the similar conductivity (~1.1 mS). 
The pH was controlled in each assay mixture at 65°C. 
 
Kinetics 
The SaADH2 kinetic parameters were calculated from measurements 
determined in duplicate or triplicate and by analysing the kinetic results 
using the program GraFit (Leatherbarrow 2004). The turnover value (kcat) 
for SaADH2 was calculated on the basis of a molecular mass of 27 kDa, 
assuming that the four subunits are catalytically active. 
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Thermophilicity and thermal stability 
SaADH2 was assayed in a temperature range of 25–90°C using standard 
assay conditions and 22 µg of protein mL–1 of assay mixture. The stability 
at various temperatures was studied by incubating 0.2-mg mL–1 protein 
samples in 50 mM Tris-HCl, pH 9.0 at temperatures between 25°C and 
95°C for 30 min. Each sample was then centrifuged at 5°C, and the residual 
activity assayed as described above. The effect of chelating agents on 
enzyme stability was studied by measuring the activities before and after 
exhaustive dialysis of the enzyme against buffer A, containing 1 mM 
EDTA, and then against buffer A alone. An aliquot of the dialysed enzyme 
was then incubated at 70°C in the absence and presence of 1 mM EDTA, 
and the activity assayed at different times. 
 
Effects of compounds on enzyme activity 
The effects of salts, metal ions, and chelating agents on SaADH2 activity 
were investigated by assaying the enzyme in the presence of an appropriate 
amount of each compound in the standard assay mixture used for the 
oxidation reaction. The effects of organic solvents were investigated by 
measuring the activity in enzyme samples (0.2 mg mL–1 in 100 mM sodium 
phosphate, pH 7.0) immediately after the addition of organic solvents at 
different concentrations and after incubation for 6 and 24 h at 50°C. The 
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percentage activity for each sample was calculated by comparison with the 
value measured prior to incubation. The volume of the solution in a tightly 
capped test tube did not change during incubation. 
 
Enantioselectivity 
The enantioselectivity of SaADH2 was determined by examining the 
reduction of acetophenone, the bicyclic ketones benzyl, and 2,2’-
dichlorobenzil using an NADH regeneration system consisting of BsADH 
and a substrate alcohol (see below). The reaction mixture contained 2 mM 
NAD+, 5 mM carbonyl compound, 4 to 18% v/v alcohol, 250 µg SaADH2, 
and 50 µg of BsADH in 1 mL of 100 mM sodium phosphate, pH 7.0. The 
reactions were carried out at 50°C for 24 h in a temperaturecontrolled water 
bath. Upon termination of the reaction, the reaction mixture was extracted 
twice with ethyl acetate. The percentage of conversion and enantiomeric 
purity of the product were determined on the basis of the peak areas of 
ketone substrates and alcohol products by HPLC, on a Chiralcel OD-H 
column (Daicel Chemical Industries, Ltd., Osaka, Japan). The absolute 
configuration of product alcohols was identified by comparing the chiral 
HPLC data with the standard samples. Products were analyzed with 
isocratic elution, under the following conditions: hexane/2-propanol (9:1) 
(mobile phase), flow rate of 1 mL min–1, detection at 210 nm. Retention 
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times were the following: 5.6, 11.9 and 16.7 for benzil, (S)- and (R)-
benzoin, respectively; 6.98, 12.73 and 15.13, for 2,2’-dichlorobenzil, (S)- 
and (R)-1,2-bis(2-chlorophenyl)-2-hydroxyethanone, respectively; 5.27, 
6.2, and 7.5 for acetophenone, (R)- and (S)-1-phenylethanol, respectively. 
The absolute stereochemistry of 1,2-bis(2-chlorophenyl)-2-
hydroxyethanone enantiomers was assigned by analogy to the values of 
(S)- and (R)-benzoin. 
 
Structural characterization 
The purified protein was concentrated to 8–10 mg mL−1 in 20 mM Tris/HCl 
buffer at pH 8.4. The protein solution was added with NADH to obtain a 
8.5 mg mL−1 protein solution containing 2.2 mM NADH in the above 
buffer. Crystallization was performed by hanging-drop vapor diffusion 
method at 296 K. The best crystals were grown by mixing 1 µl of protein 
solution with the same volume of a solution containing 2.0 M ammonium 
sulfate in 100 mM HEPES buffer (pH 7.5). The crystals belong to P21 
space group with unit cell parameters a=83.80 Å, b=60.48 Å, c=107.1 Å, 
β=99.8°. Crystals were transferred to a stabilizing solution containing 20% 
glycerol as cryoprotectant and Xray data were then collected in-house at 
100 K using a Rigaku Micromax 007 HF generator producing Cu Kα 
radiation and equipped with a Saturn944 CCD detector. Intensity data up to 
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1.75 Å resolution were processed and scaled using program HKL2000 
(HKL Research). Data collection statistics are shown in Table 19. The 
crystal structure was solved by MR methods by using as a search model the 
coordinates of a putative glucose/ribitol dehydrogenase from Clostridium 
thermocellum (PDB code 2HQ1), which showed the best sequence-
alignment with SaADH2 (39% sequence identity). Model building was first 
performed with ARP/WARP package using the warpNtrace automated 
procedure. Later model building and refinement was performed by the 
program CNS version 1.1. The final structure shows R and R-free factors 
of 17.4% and 19.5% respectively. Refinement statistics are summarized in 
Table 19. Fold similarities searches were performed with the DALI server 
(http://ekhidna.biocenter.helsinki.fi/dali_server). 
Table 19. Data collection and refinement statistics 
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BsADH Material and Methods 
Enzyme assay 
BsADH activity was assayed spectrophotometrically at 50°C by measuring 
the change in absorbance at 340 nm of NADH using a Cary 1E 
spectrophotometer equipped with a Peltier effect-controlled temperature 
cuvette holder. Measurement was carried out in 1 mL of assay mixture 
containing either 8 mM alcohol, and 18 mM NAD+ in 200 mM glycine-
NaOH, pH 8.5, or 8 mM aldehyde and 0.3 mM NADH in 100 mM Tris-
HCl, pH 7.7. Aliquots of 0.5 and 1.0 µg of BsADH were used for the 
forward and reverse reactions, respectively. One unit of BsADH 
represented 1 µmol of NADH produced or utilized per min at 50°C, on the 
basis of an absorption coefficient of 6.22 mM–1×cm–1 for NADH at 340 
nm.  
 
Kinetics 
The BsADH kinetic parameters were calculated from measurements carried 
out in duplicate or triplicate, and analysing the kinetic results using the 
program GraFit (Leatherbarrow 2004). Coefficients of variation were 
around 5% for Vmax and 16% for Km estimates. The turnover value (kcat, s–1) 
for BsADH was calculated on the basis of a molecular mass of 36 kDa, 
assuming that the four subunits are catalytically active. 
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Determination of protein concentration 
The protein concentration was determined with a Bio-Rad protein assay kit 
using bovine serum albumin as a standard (A280 of 1% bovine serum 
albumin in 50 mM sodium phosphate [pH7.0]–0.9% NaCl, 6.6). 
 
Biocatalytic synthesis of cinnamyl alcohol by isolated BsADH 
Reaction mixture for analytical biotransformation typically contained 0.125 
g L–1 (1 mM) CMA, 5 to 15% 2-propanol, 1 mM NAD+, 5 mM 2-
mercaptoethanol, 0.12 mg mL–1 BsADH in 1 mL of 50 mM sodium 
phosphate, pH 7.0. Each reaction mixture was shaken at 200 rpm for 
specific reaction times at 50°C in a temperature-controlled water bath. 
Upon termination, the reaction mixture was extracted three times with ethyl 
acetate (1:1 vol/vol). Products were analyzed by HPLC (Ultimate 3000, 
Dionex) using a Jupiter® 5 µm C18 300 Å LC column (250 × 4.6 mm 
Phenomenex, CA, USA). The degree of conversion was determined on the 
basis of the peak areas of aldehyde substrate and alcohol product eluted 
under the following conditions: 0.085% v/v H3PO4 in water (solvent A) and 
95% v/v acetonitrile in 0.085% v/v H3PO4 (solvent B) as mobile phases. 
Choromatographic conditions: initial isocratic elution, 10% B for 4 min, 
followed by a gradient phase, 10 to 90% B for 5 min, then isocratic elution 
with 90% B for 6 min, followed by a descending gradient, 90 to 10% B for 
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1 min, and isocratic elution, 10% B for 4 min at a 1 mL min–1 flow rate. 
The detector was set at 268 nm. Retention times were the following: 11.4 
and 11.9 min for CMO and CMA respectively. Semi-preparative 
biotransformations were performed on a 0.1 to 0.2 g scale in a reaction 
volume from 100 mL to 400 mL, using 0.01 to 0.05 mg mL–1 BsADH, 1 
mM NAD, in 50 mM sodium phosphate, pH 7.0, 5 mM 2-mercaptoethanol. 
The reactions were carried out at 50°C for 3 h as described above. Upon 
termination of the reaction, the mixtures were extracted three times with 
ethyl acetate (1:1 vol/vol). The combined organic layers of the ethyl acetate 
extracts were dried with anhydrous sodium sulphate, filtered, and 
concentrated under reduced pressure. Purification by silica gel column 
chromatography (hexane/ethyl acetate 9:1, the first two column volumes, 
followed by hexane/ethyl acetate 7:3) yielded CMO as colourless oils. 1H-
NMR spectra were recorded on a Bruker Biospin instrument operating at 
400 MHz. Samples were dissolved in 0.5 mL CDCl3. Chemical shifts were 
given in ppm (δ) scale; the CHCl3 signal was used as the internal standard 
(δ 7.26). 13C-NMR spectra were recorded on a Bruker Biospin instrument 
operating at 75 MHz. Samples were dissolved in 0.5 mL of CDCl3. 
Chemical shifts were given in ppm (δ) scale; the CDCl3 signal was used as 
the internal standard (δ 77.0). 
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Preparation of the whole cell catalyst 
The preparation of active cells was performed as described previously 
(Fiorentino et al. 1998). Briefly, cultures of E. coli RB791 harbouring 
BsADH were grown at 37°C in 2 L of LB medium containing 30 µg mL–1 
ampicillin. When the A600 of a culture reached 1.6, protein expression was 
induced by addition of isopropyl β-D-1-thiogalactopyranoside to 1.0 mM. 
The bacterial culture was incubated at 37°C for a further 24 h. The cell 
pellets harvested by centrifugation were stored as a 0.38 gmL–1 cell 
suspension in 50 mM sodium phosphate buffer (pH 7.0) at –20°C and used 
for biotransformation in 7 days. To determine the BsADH activity in the 
cells, an aliquot of pellet was suspended in 50 mM sodium phosphate 
buffer (pH 7.0) and lysed using a French pressure cell (Aminco Co., Silver 
Spring, MD) at 2,000 p.s.i.(1 p.s.i.= 6.9 kPa). The supernatant obtained by 
centrifugation was assayed for protein concentration and BsADH activity 
as described above, using benzyl alcohol as substrate. 
 
Biocatalytic synthesis of cinnamyl alcohol by whole-cells 
The stored wet cells of recombinant E. coli RB791 were suspended to a 
concentration of 200 to 300 mg mL–1 in 10 to 80 mL of 50 mM sodium 
phosphate buffer (pH 7.0) containing 12.5 mg mL–1 (100 mM) CMA, 10% 
2-propanol, 5 mM 2-mercaptoethanol in a 50 to 250 mL glass flask. The 
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mixture was incubated at 37°C with continuous shaking at 180 rpm. After 3 
to 6 h reaction, the work-up was carried out by lowering the pH to 3 with 
~6 M hydrochloric acid and addition of 0.75 to 6.0 g of the filter aid 
material Celite Hyflo Supercel (Macherey-Nagel) to the reaction mixture 
(0.075 g mL–1). After 30 min stirring and subsequent filtration, the filter 
cake was washed with ethyl acetate and the aqueous phase extracted three 
times with ethyl acetate (1:1 vol/vol). The resulting organic fractions were 
then combined and dried over sodium sulphate; the organic phase was 
concentrated to dryness, and the oily crude product was purified by flash 
chromatography as described above. Each sample was analysed by HPLC 
before the work-up, while NMR spectra was performed on a representative 
sample obtained from flash chromatography.   
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cofactor, substrate, co-substrate 2-propanol and biocatalyst concentrations 
on the bioreduction reaction was investigated and an efficient and 
sustainable one phase-system developed. The reduction of CMA (0.5 g/L, 
3.8 mmol/L) by the isolated enzyme occurred in 3 h at 50 °C with 97% 
conversion, and yielded high purity CMO (≥98%) with a yield of 88% and 
a productivity of 50g/g enzyme. The reduction of 12.5 g/L (94 mmol/L) CMA 
by whole cells in 6 h, at 37 °C and no requirement of external cofactor 
occurred with 97% conversion, 82% yield of 98% pure alcohol and a 
productivity of 34 g/g wet cell weight. The results demonstrate the microbial 
system as a practical and efficient method for larger scale synthesis of 
CMO.  
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